US20210010011A1 - Vectors and methods for improved plant transformation efficiency - Google Patents
Vectors and methods for improved plant transformation efficiency Download PDFInfo
- Publication number
- US20210010011A1 US20210010011A1 US16/931,315 US202016931315A US2021010011A1 US 20210010011 A1 US20210010011 A1 US 20210010011A1 US 202016931315 A US202016931315 A US 202016931315A US 2021010011 A1 US2021010011 A1 US 2021010011A1
- Authority
- US
- United States
- Prior art keywords
- dna
- cell
- plant
- seq
- spp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009466 transformation Effects 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title claims abstract description 70
- 239000013598 vector Substances 0.000 title abstract description 107
- 230000001580 bacterial effect Effects 0.000 claims abstract description 15
- 241000196324 Embryophyta Species 0.000 claims description 156
- 108020004414 DNA Proteins 0.000 claims description 89
- 241000589158 Agrobacterium Species 0.000 claims description 50
- 108090000623 proteins and genes Proteins 0.000 claims description 50
- 235000010469 Glycine max Nutrition 0.000 claims description 29
- 239000003550 marker Substances 0.000 claims description 28
- 244000068988 Glycine max Species 0.000 claims description 26
- 108700019146 Transgenes Proteins 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 21
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 21
- 108020005091 Replication Origin Proteins 0.000 claims description 20
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 19
- 235000005822 corn Nutrition 0.000 claims description 19
- 230000001131 transforming effect Effects 0.000 claims description 19
- 241000588724 Escherichia coli Species 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 229930027917 kanamycin Natural products 0.000 claims description 11
- 229960000318 kanamycin Drugs 0.000 claims description 11
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 11
- 229930182823 kanamycin A Natural products 0.000 claims description 11
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 8
- 101100301559 Bacillus anthracis repS gene Proteins 0.000 claims description 7
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 7
- 101100247969 Clostridium saccharobutylicum regA gene Proteins 0.000 claims description 7
- 108091026890 Coding region Proteins 0.000 claims description 7
- 101100136641 Escherichia coli (strain K12) pifC gene Proteins 0.000 claims description 7
- 101100412434 Escherichia coli (strain K12) repB gene Proteins 0.000 claims description 7
- 101100301564 Staphylococcus aureus repF gene Proteins 0.000 claims description 7
- 101100114425 Streptococcus agalactiae copG gene Proteins 0.000 claims description 7
- 101150044854 repA gene Proteins 0.000 claims description 7
- 101150043558 repc gene Proteins 0.000 claims description 7
- 229960000268 spectinomycin Drugs 0.000 claims description 7
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 claims description 7
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 6
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 6
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 6
- 241000589180 Rhizobium Species 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 6
- 101100184605 Escherichia coli mobA gene Proteins 0.000 claims description 5
- 108091081548 Palindromic sequence Proteins 0.000 claims description 5
- 101100391699 Pseudomonas viridiflava gacA gene Proteins 0.000 claims description 5
- 101150055347 repA2 gene Proteins 0.000 claims description 5
- 101150107738 repB gene Proteins 0.000 claims description 5
- 241000589173 Bradyrhizobium Species 0.000 claims description 4
- 241001057636 Dracaena deremensis Species 0.000 claims description 4
- 235000004341 Gossypium herbaceum Nutrition 0.000 claims description 4
- 240000002024 Gossypium herbaceum Species 0.000 claims description 4
- 241000970829 Mesorhizobium Species 0.000 claims description 4
- 241000588843 Ochrobactrum Species 0.000 claims description 4
- 241001135342 Phyllobacterium Species 0.000 claims description 4
- 241001135312 Sinorhizobium Species 0.000 claims description 4
- 230000009418 agronomic effect Effects 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 claims description 4
- 229960005322 streptomycin Drugs 0.000 claims description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 claims description 3
- 229930182566 Gentamicin Natural products 0.000 claims description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 3
- 229960000723 ampicillin Drugs 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 229960005091 chloramphenicol Drugs 0.000 claims description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 3
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 239000004098 Tetracycline Substances 0.000 claims description 2
- 108010084455 Zeocin Proteins 0.000 claims description 2
- 229930189065 blasticidin Natural products 0.000 claims description 2
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 2
- 229950010131 puromycin Drugs 0.000 claims description 2
- 229960002180 tetracycline Drugs 0.000 claims description 2
- 229930101283 tetracycline Natural products 0.000 claims description 2
- 235000019364 tetracycline Nutrition 0.000 claims description 2
- 150000003522 tetracyclines Chemical class 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 abstract description 15
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000010354 integration Effects 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 59
- 239000013612 plasmid Substances 0.000 description 47
- 239000002609 medium Substances 0.000 description 25
- 240000008042 Zea mays Species 0.000 description 20
- 230000009261 transgenic effect Effects 0.000 description 20
- 239000012634 fragment Substances 0.000 description 17
- 230000010076 replication Effects 0.000 description 16
- 239000000523 sample Substances 0.000 description 14
- 239000004009 herbicide Substances 0.000 description 13
- 150000007523 nucleic acids Chemical group 0.000 description 13
- 239000013615 primer Substances 0.000 description 12
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 11
- 239000005562 Glyphosate Substances 0.000 description 11
- 241001148115 Rhizobium etli Species 0.000 description 11
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 11
- 229940097068 glyphosate Drugs 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 11
- 102000040430 polynucleotide Human genes 0.000 description 11
- 239000002157 polynucleotide Substances 0.000 description 11
- 244000038559 crop plants Species 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 6
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000002363 herbicidal effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 244000188595 Brassica sinapistrum Species 0.000 description 5
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 5
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 5
- 108700008625 Reporter Genes Proteins 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 108020004511 Recombinant DNA Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 3
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 3
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 3
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 3
- 108010000700 Acetolactate synthase Proteins 0.000 description 3
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 3
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 229960003669 carbenicillin Drugs 0.000 description 3
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 3
- 230000010307 cell transformation Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000007479 molecular analysis Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NDUPDOJHUQKPAG-UHFFFAOYSA-M 2,2-Dichloropropanoate Chemical compound CC(Cl)(Cl)C([O-])=O NDUPDOJHUQKPAG-UHFFFAOYSA-M 0.000 description 2
- GOCUAJYOYBLQRH-UHFFFAOYSA-N 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-UHFFFAOYSA-N 0.000 description 2
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 239000005489 Bromoxynil Substances 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000006740 Cichorium endivia Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 239000005504 Dicamba Substances 0.000 description 2
- 102000016680 Dioxygenases Human genes 0.000 description 2
- 108010028143 Dioxygenases Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 239000005561 Glufosinate Substances 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 244000299507 Gossypium hirsutum Species 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 101000798707 Homo sapiens Transmembrane protease serine 13 Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 239000005571 Isoxaflutole Substances 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 241000134253 Lanka Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 241000589195 Mesorhizobium loti Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 239000005595 Picloram Substances 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 101100173636 Rattus norvegicus Fhl2 gene Proteins 0.000 description 2
- 241000749897 Rhizobium etli CFN 42 Species 0.000 description 2
- 241000589187 Rhizobium sp. Species 0.000 description 2
- 241000589196 Sinorhizobium meliloti Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 101000951943 Stenotrophomonas maltophilia Dicamba O-demethylase, oxygenase component Proteins 0.000 description 2
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 102100032467 Transmembrane protease serine 13 Human genes 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000003733 chicria Nutrition 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- OILAIQUEIWYQPH-UHFFFAOYSA-N cyclohexane-1,2-dione Chemical compound O=C1CCCCC1=O OILAIQUEIWYQPH-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- OYIKARCXOQLFHF-UHFFFAOYSA-N isoxaflutole Chemical compound CS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1=C(C2CC2)ON=C1 OYIKARCXOQLFHF-UHFFFAOYSA-N 0.000 description 2
- 229940088649 isoxaflutole Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000027086 plasmid maintenance Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 229960004659 ticarcillin Drugs 0.000 description 2
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical compound OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 description 1
- MZHCENGPTKEIGP-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1Cl MZHCENGPTKEIGP-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- GQQIAHNFBAFBCS-UHFFFAOYSA-N 2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluorophenoxy]acetic acid Chemical compound C1=C(Cl)C(OCC(=O)O)=CC(N2C(C3=C(CCCC3)C2=O)=O)=C1F GQQIAHNFBAFBCS-UHFFFAOYSA-N 0.000 description 1
- OOLBCHYXZDXLDS-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(Cl)C=C1Cl OOLBCHYXZDXLDS-UHFFFAOYSA-N 0.000 description 1
- ABOOPXYCKNFDNJ-UHFFFAOYSA-N 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 ABOOPXYCKNFDNJ-UHFFFAOYSA-N 0.000 description 1
- JICQIUSBYUOAED-UHFFFAOYSA-N 3-cyclopropyl-1,2-oxazole Chemical compound C1CC1C1=NOC=C1 JICQIUSBYUOAED-UHFFFAOYSA-N 0.000 description 1
- AEDORKVKMIVLBW-BLDDREHASA-N 3-oxo-3-[[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methoxy]oxan-2-yl]methoxy]propanoic acid Chemical compound OCC1=C(O)C(C)=NC=C1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](COC(=O)CC(O)=O)O1 AEDORKVKMIVLBW-BLDDREHASA-N 0.000 description 1
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 1
- HUNCSWANZMJLPM-UHFFFAOYSA-N 5-methyltryptophan Chemical compound CC1=CC=C2NC=C(CC(N)C(O)=O)C2=C1 HUNCSWANZMJLPM-UHFFFAOYSA-N 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 241000242764 Aequorea victoria Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108010037870 Anthranilate Synthase Proteins 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 239000005506 Diclofop Substances 0.000 description 1
- 101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 1
- 108700016256 Dihydropteroate synthases Proteins 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 239000005558 Fluroxypyr Substances 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 108030006517 Glyphosate oxidoreductases Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- GHSJKUNUIHUPDF-BYPYZUCNSA-N L-thialysine Chemical compound NCCSC[C@H](N)C(O)=O GHSJKUNUIHUPDF-BYPYZUCNSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 235000001591 Pachyrhizus erosus Nutrition 0.000 description 1
- 244000215747 Pachyrhizus erosus Species 0.000 description 1
- 235000018669 Pachyrhizus tuberosus Nutrition 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000254064 Photinus pyralis Species 0.000 description 1
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241001236219 Pinus echinata Species 0.000 description 1
- 235000005018 Pinus echinata Nutrition 0.000 description 1
- 235000017339 Pinus palustris Nutrition 0.000 description 1
- 235000008577 Pinus radiata Nutrition 0.000 description 1
- 241000218621 Pinus radiata Species 0.000 description 1
- 241000218679 Pinus taeda Species 0.000 description 1
- 235000008566 Pinus taeda Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- CSPPKDPQLUUTND-NBVRZTHBSA-N Sethoxydim Chemical compound CCO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O CSPPKDPQLUUTND-NBVRZTHBSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101100277341 Stenotrophomonas maltophilia ddmC gene Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 239000005627 Triclopyr Substances 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 101150067314 aadA gene Proteins 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical class O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 235000000183 arugula Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 101150011371 dapA gene Proteins 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- MEFQWPUMEMWTJP-UHFFFAOYSA-N fluroxypyr Chemical compound NC1=C(Cl)C(F)=NC(OCC(O)=O)=C1Cl MEFQWPUMEMWTJP-UHFFFAOYSA-N 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- 108010039239 glyphosate N-acetyltransferase Proteins 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000012499 inoculation medium Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- NVGOPFQZYCNLDU-UHFFFAOYSA-N norflurazon Chemical compound O=C1C(Cl)=C(NC)C=NN1C1=CC=CC(C(F)(F)F)=C1 NVGOPFQZYCNLDU-UHFFFAOYSA-N 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- UHSGPDMIQQYNAX-UHFFFAOYSA-N protoporphyrinogen Chemical class C1C(=C(C=2C=C)C)NC=2CC(=C(C=2CCC(O)=O)C)NC=2CC(N2)=C(CCC(O)=O)C(C)=C2CC2=C(C)C(C=C)=C1N2 UHSGPDMIQQYNAX-UHFFFAOYSA-N 0.000 description 1
- 101150075980 psbA gene Proteins 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- YXIIPOGUBVYZIW-UHFFFAOYSA-N pyraflufen Chemical compound ClC1=C(OC(F)F)N(C)N=C1C1=CC(OCC(O)=O)=C(Cl)C=C1F YXIIPOGUBVYZIW-UHFFFAOYSA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 125000005554 pyridyloxy group Chemical group 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver nitrate Substances [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical compound BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 description 1
- REEQLXCGVXDJSQ-UHFFFAOYSA-N trichlopyr Chemical compound OC(=O)COC1=NC(Cl)=C(Cl)C=C1Cl REEQLXCGVXDJSQ-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C12R1/41—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/41—Rhizobium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the invention relates generally to the field of molecular biology. More specifically, the invention relates to improved methods for plant genetic transformation and compositions for achieving the same.
- Transformation of plant cells by an Agrobacterium -mediated method involves exposing plant cells and tissues to a suspension of Agrobacterium cells that contain certain DNA plasmids. These plasmids have been specifically constructed to contain transgenes that will express in plant cells (see, for example, U.S. Pat. No. 5,034,322). Most often, one or more of the transgenes is a positive selectable marker transgene that permits plant cells to grow in the presence of a positive selection compound, such as an antibiotic or herbicide. These cells can be further manipulated to regenerate into whole fertile plants.
- a positive selection compound such as an antibiotic or herbicide.
- the methods for introducing transgenes into plants by an Agrobacterium -mediated transformation method generally involve a T-DNA (transfer DNA) that incorporates the genetic elements of at least one transgene and transfers those genetic elements into the genome of a plant.
- the transgene(s) are typically constructed in a DNA plasmid vector and are usually flanked by an Agrobacterium Ti plasmid right border DNA region (RB) and a left border DNA region (LB).
- RB right border DNA region
- LB left border DNA region
- the DNA plasmid is nicked by an endonuclease, VirD2, at the right and left border regions.
- a single strand of DNA from between the nicks, called the T-strand is transferred from the Agrobacterium cell to the plant cell.
- the sequence corresponding to the T-DNA region is inserted into the plant genome.
- the integration of the T-DNA into the plant genome generally begins at the RB and continues to the end of the T-DNA, at the LB. However, the endonucleases sometimes do not nick equally at both borders. When this happens, the T-DNA that is inserted into the plant genome often contains some or all of the plasmid vector DNA. This phenomenon is referred to as “border read-through.” It is usually preferred that only the transgene(s) located between the right and left border regions (the T-DNA) is transferred into the plant genome without any of the adjacent plasmid vector DNA (the vector backbone).
- the vector backbone DNA contains various plasmid maintenance elements, including for example, origin of replications, bacterial selectable marker genes, and other DNA fragments that are not required to express the desired trait(s) in commercial crop products.
- constructs and methods are provided for improving the quality of events in bacterially-mediated plant cell transformation, such as Agrobacterium -mediated plant transformation.
- the invention is advantageous in providing a reduced frequency of vector backbone DNA, i.e., non-T-DNA region, transformation events and of increasing the frequency of T-DNA transformation events with one or two copies of the T-DNA.
- the invention also provides DNA constructs for transforming plants comprising: i) at least one T-DNA border region; ii) at least one heterologous transgene adjacent to the border region; iii) a coding region for a bacterial selectable marker; and iv) at least one segment of DNA, comprising a cis and/or trans element or elements of a replication origin for maintaining a low copy number of the DNA construct in a plant cell transforming bacterium.
- the elements of the replication origin for maintaining low copy number of a DNA construct in a plant cell transforming (plant cell transformation competent) bacterial cell comprise one or more of repA (e.g. SEQ ID NO:32 or SEQ ID NO:38); repB (e.g. SEQ ID NO:33 or SEQ ID NO:39); repC (e.g. SEQ ID NO:34 or SEQ ID NO:40); igsl (e.g. SEQ ID NO:35 or SEQ ID NO:41); igs2 (e.g. SEQ ID NO:36 or SEQ ID NO:42).
- a construct may also optionally include a palindromic sequence, for example, the 16 bp palindromic sequence of SEQ ID NO:37. These elements may be arranged in cis or in trans with respect to each other.
- the a T-DNA border region is defined as a right border region (RB) or a left border (LB) region.
- the RB and/or LB sequences comprise SEQ ID NO:43 or SEQ ID NO:44.
- a heterologous transgene when expressed in a transformed plant cell provides an agronomic phenotype to the cell or transformed plant derived from the cell.
- a coding region for a bacterial selectable marker is an antibiotic resistance gene selected from kanamycin resistance gene, gentamycin resistance gene, chloramphenicol resistance gene, spectinomycin resistance gene, streptomycin resistance gene, tetracycline resistance gene, ampicillin resistance gene, blasticidin resistance gene, hygromycin resistance gene, puromycin resistance gene, or Zeocin resistance gene.
- a replication origin comprises a repABC sequence selected from SEQ ID NOs: 1, 2, 3, or 4.
- the at least one segment of DNA comprises replication genes repA, repB, and repC.
- the at least one segment of DNA comprises intergenic sequence 1 (igs1) and intergenic sequence 2 (igs2).
- the at least one segment of DNA comprises a 16 base pair palindromic sequence.
- the segment of DNA comprises all sequences of repABC necessary for maintaining low copy number (1-3 copies per cell) in Agrobacterium or other plant cell transforming competent bacteria. Constructs containing repABC and methods or their use are described in more detail below.
- the DNA constructs of the present invention may be transferred to any cell, for example, such as a plant cell transformation competent bacterium.
- a plant cell transformation competent bacterium Such bacteria are known in the art and may, for instance, belong to the following species: Agrobacterium spp., Rhizobium spp., Sinorhizobium spp., Mesorhizobium spp., Phyllobacterium spp. Ochrobactrum spp. and Bradyrhizobium spp.
- such bacteria may belong to Agrobacterium spp.
- the DNA constructs of the present invention may further comprise one or more replication origins for maintaining copies of the construct in E. coli .
- origin of replication for maintaining copies of the construct in E. coli is derived from at least one of pBR322 and pUC.
- the present invention also relates to a plant cell transforming bacterium comprising the DNA construct of the present invention, and which may be used for transforming a plant cell.
- the plant transforming bacteria is selected from Agrobacterium spp., Rhizobium spp., Sinorhizobium spp., Mesorhizobium spp., Phyllobacterium spp. Ochrobactrum spp. or Bradyrhizobium spp.
- the present invention also relates to a method for transforming a plant cell comprising: contacting at least a first plant cell with a plant cell transforming bacteria of the present invention; and selecting at least a plant cell transformed with at least one heterologous transgene.
- the plant cell is a soybean, canola, corn, or cotton plant cell.
- a method of the invention further comprises regenerating a plant from the plant cell.
- the present invention also relates to a method of producing food, feed or an industrial product comprising: obtaining the plant of the present invention or a part thereof; and preparing the food, feed or industrial product from the plant or part thereof.
- the invention also includes methods of genetically transforming plants with the DNA constructs of the present invention and reducing the frequency of plants transformed with non-T DNA vector region
- the frequency of plants transformed with non-T-DNA region may be defined as less than or equal to about 20%.
- the frequency is less than or equal to about 15%, in some embodiments less than about 10%, and in some embodiments less than or equal to about 8% or 5%.
- the frequency of one- or two-copy T-DNA transformation events obtained is greater than or equal to about 70% or 75%. In some instances, that frequency can be raised to greater than or equal to about 80% or 85%, and in some embodiments, to greater than about 90% or 95%.
- the present invention encompasses plant transformation vectors containing mutants and variants of oriRi that retain substantially similar function to the full length sequence when used in the present invention.
- mutants and variants of oriRi that retain substantially similar function to the full length sequence when used in the present invention.
- applicants have identified the truncated sequence disclosed in SEQ ID NO: 3 that is suitable for use in the present invention.
- One of skill in the art can readily make additional changes, deletions, substitutions, etc in the oriRi sequence and screen for functional activity using the methods of the present invention.
- the present invention encompasses such variants and mutants.
- FIG. 1 shows a plasmid map of pMON 83856 , the base vector with a 5.6 kb oriRi fragment used for construction of pMON 83882 for soybean transformation and pMON 97352 for corn transformation.
- FIG. 2 shows a plasmid map of pMON 83882 , the testing vector with a 5.6 kb oriRi fragment and 5-enolpyruvylshikimate-3-phosphate synthase (CP4-EPSPS) selectable marker gene and the uidA (gus) gene of interest, as an example, for soy transformation.
- CP4-EPSPS 5-enolpyruvylshikimate-3-phosphate synthase
- FIG. 3 shows a plasmid map of pMON 83934 , a base vector with a 4.2 kb oriRi fragment used for construction of pMON 83937 .
- FIG. 4 shows a plasmid map of pMON 83937 , a testing vector with a 4.2 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soy transformation.
- FIG. 5 shows a plasmid map of pMON 97352 , a test vector with a 5.6 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for corn transformation.
- FIG. 6 shows a plasmid map of pMON 92726 which was used as a control for corn transformation. It contains the same gene structure as pMON 97352 except for the replication origin. It contains ori V instead of oriRi.
- FIG. 7 shows a plasmid map of pMON 87488 , a 2 T-DNA transformation vector, which was used as a control for soybean transformation. It contains ori V instead of oriRi.
- FIG. 8 shows a plasmid map of pMON 96001 , a 2 T-DNA transformation test vector with a 4.3 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soybean transformation.
- FIG. 9 shows a plasmid map of pMON 96010 , a 2 T-DNA transformation test vector with a 5.6 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soybean transformation.
- FIG. 10 shows the effect of type of replication origin on transformation frequency in corn. Error bars represent the 95% confidence interval; * indicates a significant difference between oriRi (pMON 97352 ) and oriV (pMON 92726 ).
- FIG. 11 shows the effect of type of replication origin on backbone sequence transfer in corn transformation. Error bars represent the 95% confidence interval; * indicates a significant difference between oriRi (pMON 97352 ) and oriV (pMON 92726 ). oriRi/ori V, RB, and LB indicates the type of backbone probe used.
- FIG. 12 shows the effect of type of replication origin on transgene quality in corn transformation. Error bars represent the 95% confidence interval. 0, 1, 2, 3+indicates copy number.
- FIG. 13 shows a plasmid map of pMON 96951 containing repABC replication origin from Rhizobium etli CFN42 p42b plasmid and CP4 EPSPS selectable marker gene for soybean.
- the present invention relates, in part, to the discovery that the repABC origin of replication, such as the one from Agrobacterium rhizogenes pRi (“oriRi” or “oriPRi”), which maintains 1-3 copies in bacteria such as Agrobacterium, can be used in plant transformation vectors and can impart highly desirable transformation events.
- the vectors of the invention can, for example, significantly reduce the frequency of transformation events that transfer non-T-DNA region, i.e., vector backbone DNA, and can, for example, significantly increase the number of one- or two-copy T-DNA, i.e., the gene of interest, transformation events.
- the prior art does not teach or suggest the use of oriRi to achieve these unexpected transformation results.
- the vectors and methods of the invention improve transformation events in the preparation of transgenic crop plants.
- a transgenic crop plant contains an exogenous polynucleotide molecule or a heterologous transgene inserted into the genome of a crop plant cell.
- a crop plant cell includes without limitation, a plant cell, and further comprises suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, ovules, pollen and microspores, and seeds, and fruit.
- exogenous or heterologous it is meant that a polynucleotide molecule which originates from outside the plant cell into which the polynucleotide molecule is introduced.
- exogenous polynucleotide molecule can have a naturally occurring or non-naturally occurring nucleotide sequence.
- an exogenous polynucleotide molecule can be a heterologous molecule derived from a different species of any other organism or the plant species than the plant into which the polynucleotide molecule is introduced or can be a polynucleotide molecule derived from the same plant species as the plant into which it is introduced.
- the exogenous polynucleotide when expressed in a transformed plant cell provides an agronomic trait to the cell or to a transformed plant derived from the cell.
- genes of interest provide beneficial agronomic traits to crop plants, for example, including, but not limited to genetic elements comprising herbicide resistance (U.S. Pat. Nos. 5,633,435; 5,463,175), increased yield (U.S. Pat. No. 5,716,837), insect control (U.S. Pat. Nos. 6,063,597; 6,063,756; 6,093,695; 5,942,664; 6,110,464), fungal disease resistance (U.S. Pat. Nos.
- the present invention provides plant recombinant DNA constructs for producing transgenic crop plants.
- Methods that are well known to those skilled in the art may be used to prepare the crop plant recombinant DNA construct of the present invention. These methods include in vitro recombinant DNA techniques, synthetic techniques, and in vivo genetic recombination. Such techniques are described in Sambrook et al. (1989). Exogenous polynucleotide molecules created by the methods may be transferred into a crop plant cell by a plant transforming bacterium such as Agrobacterium or by other methods known to those skilled in the art of plant transformation. Gene transfer to plants has been shown using diverse species of bacteria as described in Broothaerts et al. (2005) and the U.S.
- the recombinant DNA constructs of the present invention may be transferred into a crop plant cell by transformation using Sinorhizobium meliloti , Rhizobium sp., Mesorhizobium loti , or any other bacterium capable of transforming a plant cell.
- the invention includes plant transformation vectors for use in Agrobacterium -mediated transformation of plants.
- the vectors of the present invention are generally plasmids, but the oriRi replication origin may be replaced by other replication origins from the repABC family for maintaining very low copy number (1-3 copies per cell) in Agrobacterium .
- vectors without an Agrobacterium -maintaining replication origin are capable of maintaining themselves in Agrobacterium with sequences in the T-DNA that can be integrated into either the Ti plasmid in A. tumefaciens , Ri plasmid in A. rhizogenes or Agrobacterium chromosome through homologous recombination.
- T-DNA containing GOI can be integrated into the chromosome or into repABC plasmids in the host bacteria, which can produce the same effect as Agrobacterium does.
- a vector of the present invention may comprise at least one of Agrobacterium Ti plasmid right border or left border region.
- the vectors may comprise at least one pair of borders.
- the vectors can include four pairs of borders, but the vector often comprise one or two pairs.
- the vectors of the present invention may further comprise a coding region for a selectable marker for the maintenance in bacterial hosts.
- Coding regions for selectable markers include Spec/Strp that encodes for Tn7 aminoglycoside adenyltransferase (aadA) conferring resistance to spectinomycin or streptomycin, or a gentamycin (Gm, Gent) selectable marker gene.
- Other resistance genes include carbenecillin, ampicillin, and kanamycin resistance genes. Others are known and may be readily used in the present invention by those of skill in the art.
- the vectors of the present invention may also comprise a coding region for a plant selectable marker gene, which is typically located in T-DNA, to select transformed plant cells with the corresponding reagent.
- the plant selectable marker may provide resistance to a positive selection compound, for example, antibiotic resistance (e.g., kanamycin, G418, bleomycin, hygromycin, etc.), or herbicide resistance (e.g., including but not limited to: glyphosate, Dicamba, glufosinate, sulfonylureas, imidazolinones, bromoxynil, dalapon, cyclohexanedione, protoporphyrinogen oxidase inhibitors, and isoxaflutole herbicides).
- antibiotic resistance e.g., kanamycin, G418, bleomycin, hygromycin, etc.
- herbicide resistance e.g., including but not limited to: glyphosate, Dicamba,
- Polynucleotide molecules encoding proteins involved in herbicide tolerance include, but are not limited to a polynucleotide molecule encoding a) tolerance to a glyphosate include 5-enolpyruvylshikimate-3-phosphate synthases (EP SPS; U.S. Pat. Nos. 5,627,061, 5,633,435, 6,040,497, 5,094,945, WO04074443, and WO04009761), glyphosate oxidoreductase (GOX; U.S. Pat. No. 5,463,175), glyphosate decarboxylase (WO05003362 and U.S.
- EP SPS 5-enolpyruvylshikimate-3-phosphate synthases
- U.S. Pat. Nos. 5,627,061, 5,633,435, 6,040,497, 5,094,945, WO04074443, and WO04009761 5-enolpyruvy
- Patent Application 20040177399) and glyphosate-N-acetyl transferase (GAT; U.S. Patent publication 20030083480) conferring tolerance to glyphosate; b) dicamba monooxygenase (DMO, encoded by ddmC) conferring tolerance to auxin-like herbicides such as dicamba (U.S. Patent Applications 20030115626, 20030135879; Herman et al., 2005); c) phosphinothricin acetyltransferase (bar) conferring tolerance to phosphinothricin or glufosinate (U.S. Pat. Nos.
- DMO dicamba monooxygenase
- bar conferring tolerance to phosphinothricin or glufosinate
- dihydropteroate synthase for conferring tolerance to sulfonamide herbicides (U.S. Pat. Nos. 5,597,717; 5,633,444; 5,719,046); i) 32 kD photosystem II polypeptide (psbA) for conferring tolerance to triazine herbicides (Hirschberg et al., 1983); j) anthranilate synthase for conferring tolerance to 5-methyltryptophan (U.S. Pat. No.
- herbicides examples include phenoxy auxins (such as 2,4-D and dichlorprop), pyridyloxy auxins (such as fluroxypyr and triclopyr), aryloxyphenoxypropionates (AOPP) acetyl- coenzyme A carboxylase (ACCase) inhibitors (such as haloxyfop, quizalofop, and diclofop), and 5- substituted phenoxyacetate protoporphyrinogen oxidase IX inhibitors (such as pyraflufen and flumiclorac).
- phenoxy auxins such as 2,4-D and dichlorprop
- pyridyloxy auxins such as fluroxypyr and triclopyr
- AOPP aryloxyphenoxypropionates
- reporter gene In addition to a plant selectable marker, in some embodiments it may be desirable to use a reporter gene. In some instances, a reporter gene may be used with or without a selectable marker. Reporter genes are genes that are typically not present in the recipient organism or tissue and typically encode for proteins resulting in some phenotypic change or enzymatic property. Examples of such genes are provided in Wising et al. (1988), that is incorporated herein by reference. Preferred reporter genes include the beta-glucuronidase (GUS) of the uidA locus of E. coli , the chloramphenicol acetyl transferase gene from Tn9 of E.
- GUS beta-glucuronidase
- GUS beta-glucuronidase
- the vectors of the present invention comprise one replication origin for maintenance in E. coli .
- These origins of replication may be derived, for example, from pBR322 or from pUC.
- One example of such an origin of replication is ColE1.
- the vectors of the present invention can include any origin of replication which maintains at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, or 100 or more plasmid copies in E. coli .
- the ori maintains a higher copy number in E. coli (e.g., greater than 5, 10, 15, 20, 25, or 30, and in some further embodiments, greater than 10, 15, 20, 25 or 30).
- the present invention includes a vector containing an ori that provides high copy numbers in E. coli cells, and a second ori, such as an ori belonging to the repABC family, for example, oriRi, that maintains extremely low copy number, for example 1-3, in Agrobacterium.
- the vectors of the present invention also comprise at least one segment of DNA, comprising cis and/or trans elements, which is necessary and sufficient for low-copy plasmid maintenance (1-3 copies) in a plant transforming bacterium such as Agrobacterium .
- the at least one segment of DNA preferably comprises an origin of replication from the repABC family.
- the at least one segment of DNA may include a Ri plasmid replication origin of Agrobacterium rhizogenes (oriRi) and/or repABC origin from plasmid p42b of Rhizobium etli.
- the repABC family preferably comprises replication genes repA, repB, and repC.
- the at least one segment also may comprise intergenic region sequences, igs1 and igs2.
- the at least one segment of DNA may include a 16-bp palindrome after repC.
- the “origin of replication” of a “repABC” plasmid i.e. a plasmid that utilizes such sequences for replication and partitioning in a cell, may be defined as comprising repA (e.g. SEQ ID NO:32 from pRi of A. rhizogenes; SEQ ID NO:38 from p42b of R. etli), repB (e.g. SEQ ID NO: SEQ ID NO:33 from A. rhizogenes; SEQ ID NO:39 from p42b of R. etli), repC (e.g. SEQ ID NO: SEQ ID NO:34 from A.
- repA e.g. SEQ ID NO:32 from pRi of A. rhizogenes; SEQ ID NO:38 from p42b of R. etli
- repB e.g. SEQ ID NO: SEQ ID NO:33 from A. rhizogenes;
- rhizogenes SEQ ID NO:40 from p42b of R. etli),igsl (e.g. SEQ ID NO:35 from A. rhizogenes; SEQ ID NO:41 from p42b of R. etli)), igs2 (e.g. SEQ ID NO:36 from A. rhizogenes; SEQ ID NO:42 from p42b of R. etli), and may optionally comprise a palindromic sequence (e.g. SEQ ID NO:37).
- the origin of replication may comprise those sequences required for maintaining low copy number (for example, from 1 to about 3 copies) within a plant-cell-transforming bacterial cell.
- repABC origins of replication are found in SEQ ID NOs:1-4, in the oriRi of the Ri plasmid of A. rhizogenes, and in plasmid p42b of R. etli, among others.
- the at least one segment is as identified in SEQ ID NO:1. In other embodiments, the at least one segment consists essentially of the following sequence: 5618 bp oriRi of pMON83882 bases (633-6250) identified as SEQ ID NO:2. In another embodiment, the at least one segment comprises and/or consists essentially of the sequence identified in SEQ ID NO:3. In yet another embodiment, the at least one segment may be repABC from p42b from R. etli as identified in SEQ ID NO:4.
- nucleic acid or polypeptide sequence defined herein are sequences which exhibit a specified degree of identity to such sequences.
- modifications may be made to the described sequences without departing from the scope of the invention.
- nucleic acid sequences which are substantially identical to those set forth herein may be used with the present invention.
- a first nucleic acid sequence displays “substantial identity” to a reference nucleic acid sequence if, when optimally aligned (with appropriate nucleotide insertions or deletions totaling less than 20 percent of the reference sequence over the window of comparison) with the other nucleic acid (or its complementary strand), there is at least about 75% nucleotide sequence identity, preferably at least about 80% identity, more preferably at least about 85%, 86%, 87%, 88%, or 89% identity, and most preferably at least about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identity over a comparison window of at least 200 nucleotide positions, preferably at least 300 nucleotide positions, more preferably at least 400 nucleotide positions, and most preferably over the entire length of the first nucleic acid.
- Optimal alignment of sequences for aligning a comparison window may be conducted by the similarity method of Pearson and Lipman (1988); preferably by computerized implementations of these algorithms in the Wisconsin Genetics Software Package Release 7.0, Genetics Computer Group, Madison, Wis.
- the reference nucleic acid may be a full-length molecule or a portion of a longer molecule.
- stringent hybridization conditions is defined as conditions under which a test sequence hybridizes specifically with a target sequence(s) but not with non-target sequences, as can be determined empirically.
- stringent conditions is functionally defined with regard to the hybridization of a nucleic-acid probe to a target nucleic acid (i.e., to a particular nucleic-acid sequence of interest) by the specific hybridization procedure (see for example Sambrook et al., 1989, at 9.52-9.55, Sambrook et al., 1989 at 9.47-9.52, 9.56-9.58; Kanehisa, 1984; and Wetmur and Davidson, 1968).
- Appropriate stringent conditions for DNA hybridization are, for example, 6.0x sodium chloride/sodium citrate (SSC) at about 45° C., followed by a wash of 0.2x SSC at 50° C.
- lower stringency conditions may be used by changing the wash to about 2.0x SSC at 50° C.
- the temperature in the wash step can be increased from low stringency conditions at room temperature, about 22° C., to higher stringency conditions at about 65° C.
- Both temperature and salt may be varied, or either the temperature or the salt concentration may be held constant while the other variable is changed.
- hybridization using DNA or RNA probes or primers can be performed at 65° C.
- a nucleic acid molecule is said to be the “complement” of another nucleic acid molecule if they exhibit complete complementarity.
- molecules are said to exhibit “complete complementarity” when every nucleotide of one of the molecules is complementary to a nucleotide of the other.
- Two molecules are said to be “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low stringency” conditions.
- the molecules are said to be “complementary” is they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high stringency” conditions.
- lower stringency hybridization conditions such as lower hybridization and/or washing temperatures can be used to identify related sequences having a lower degree of sequence similarity if specificity of binding of the probe or primer to target sequence(s) is preserved.
- the nucleotide sequences of the present invention can be used for their ability to selectively form duplex molecules with complementary stretches of DNA fragments. Detection of DNA segments via hybridization is well-known to those of skill in the art, and thus depending on the application envisioned, one will desire to employ varying hybridization conditions to achieve varying degrees of selectivity of probe towards target sequence and the method of choice will depend on the desired results. Conventional stringency conditions are described in Sambrook, et al. (1989) and by Haymes et al. (1985).
- the DNA construct of the present invention may be introduced into the genome of a desired plant host by a suitable Agrobacterium -mediated plant transformation method.
- Methods for transforming plants by Agrobacterium tumefaciens -mediated transformation include: Fraley et al., (1985), and Rogers et al., (1987).
- Agrobacterium -mediated transformation is achieved through the use of a genetically engineered soil bacterium belonging to the genus Agrobacterium .
- Several Agrobacterium species mediate the transfer of a specific DNA known as “T-DNA,” that can be genetically engineered to carry any desired piece of DNA into many plant species.
- T-DNA mediated pathogenesis The major events marking the process of T-DNA mediated pathogenesis are induction of virulence genes, and processing and transfer of the T-strand. This process is the subject of many reviews (Ream, 1989; Howard and Citovsky, 1990; Kado, 1991; Winans, 1992; Zambryski, 1992; Gelvin, 1993; Binns and Howitz, 1994; Hooykaas and Beijersbergen, 1994; Lessl and Lanka, 1994; Zupan and Zambryski, 1995).
- Non-Agrobacterium species such as Sinorhizobium meliloti, Rhizobium sp., Mesorhizobium loti , may also be used for transferring genes using the DNA constructs of the present invention (Broothaerts et al., 2005 and the U.S. provisional application 60/800,872, herein incorporated by reference).
- Other methods for introducing DNA into cells may also be used. These methods are well known to those of skill in the art and can include to chemical methods and physical methods such as microinjection, electroporation, and micro-projectile bombardment.
- Plant cell regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, also typically relying on a biocide and/or herbicide marker that has been introduced together with the desired nucleotide sequences.
- Methods and compositions for transforming plants by introducing a transgenic DNA construct into a plant genome in the practice of this invention can include any of the well-known and demonstrated methods. For example, Agrobacterium -mediated transformation as illustrated in U.S. Pat. Nos. 5,824,877; 5,591,616; and 6,384,301, all of which are incorporated herein by reference.
- Plants that can be made by practice of the present invention include any plants that are subject to transformation and regeneration and include, but are not limited to, Acacia, alfalfa, aneth, apple, apricot, artichoke, arugula, asparagus, avocado, banana, barley, beans, beet, blackberry, blueberry, broccoli, brussels sprouts, cabbage, canola, cantaloupe, carrot, cassava, cauliflower, celery, Chinese cabbage, cherry, cilantro, citrus, clementines, coffee, corn, cotton, cucumber, Douglas fir, eggplant, endive, escarole, eucalyptus, fennel, figs, forest trees, gourd, grape, grapefruit, honey dew, jicama, kiwifruit, lettuce, leeks, lemon, lime, Loblolly pine, mango, melon, mushroom, nut, oat, okra, onion, orange, an ornamental plant, papaya, parsley, pea, peach, peanut,
- the plant is a soybean, corn, canola, or cotton plant.
- the plant is a corn plant.
- the plant is a soybean plant.
- the plant is a cotton plant.
- the plant is a canola plant.
- the present methods yield improved transformation efficiencies, significantly reducing the frequency of plants transformed with vector backbone DNA, or “non-T-DNA.”
- the frequency of plants transformed with non-T DNA is less than or equal to about 20%.
- the frequency of plants transformed with non-T DNA is less than or equal to about 15%, or less than equal to about 10%, or less than or equal to about 8% or 5%.
- the methods of the invention yield very high one- or two- copy T-DNA transformation events.
- the frequency of one- or two-copy T-DNA transformation events is greater than or equal to about 70% or 75%, as measured using Southern blotting. In some embodiments, that frequency is greater than or equal to about 80% or 85%, and in some cases, 90% or 95%, as measured with Southern blotting.
- the frequency of plants transformed with non-T DNA vector region is about 50%, 40%, 20%, 15%, or 10% lower than the frequency of T-DNA found in the same variety of plant that has been transformed with a plant transformation vector that does not contain the repABC element such as oriRi element of the present invention.
- the frequency of one- or two-copy T-DNA transformation events is about 50%, 40%, 20%, 15%, or 10% higher than the frequency of one- or two-copy T-DNA transformation events relative to the same variety of plant transformed with plant transformation vector that does not contain the repABC element such as oriRi element of the present invention.
- certain embodiments of the present invention provide methods involving use of repABC element such as oriRi from Agrobacterium rhizogenes and repABC origin from plasmid p42b of Rhizobium etli , including the sequences set forth herein, to reduce the frequency of plants transformed with non-T-DNA vector region.
- the present invention is also directed to the use of repABC element such as oriRi from Agrobacterium rhizogenes and repABC origin from plasmid p42b of Rhizobium etli, including the sequences set forth herein, to increase the frequency of one- or two-copy T-DNA transformation events.
- both methods are employed in combination to achieve transformation events having lower frequencies of backbone incorporation and higher frequencies of one- or two- copy T-DNA transformation events.
- the PCR product was purified and inserted into pMON 83930 , which was digested with Afel and Xhol and blunted with T4 DNA polymerase, to replace oriV fragment.
- the resulting vector pMON 83934 ( FIG. 3 ), with the truncated oriRi, was then confirmed by DNA sequencing.
- the testing vector pMON 83937 ( FIG. 3 )
- pMON 83934 was opened with KpnI, blunted with T4 DNA polymerase, and followed by BamHI digestion; the gus and Cp4 fragment from oriV control vector pMON 67438 was sequentially digested with AccI, filled in with T4 DNA polymerase, and then further digested with BamHI. The two fragments were ligated with T4 DNA ligase and resulted in pMON 83937 .
- a linker sequence containing Spel and PspOMI sites were synthesized by annealing two oligos 5′-AGCTTGGGCCCCTCGAGGCTAGCACTAGTG-3′ (SEQ ID NO:7 and 5′-GATCCACTAGTGCTAGCCTCGAGGGGCCCA-3′ (SEQ ID NO: 8), and inserted into pMON 83856 with the BamHI and HindIII digestion.
- the resulting intermediate oriRi vector was opened with Spel and PspOMI and ligated with the CP4 and gus expression cassettes excised from pMON 92726 ( FIG. 6 ) with Notl and SpeI digestion (see FIG. 5 , pMON 97352 ).
- the oriV parental vector pMON 992726 was used as a control vector to compare with corn oriRi test vector pMON 97352 .
- oriV 2T control vector pMON 87488 ( FIG. 7 ) the octopine right border was excised from pMON 51676 , blunted with T4 DNA polymerase and inserted into pMON 87485 which was opened with SalI/SpeI, filled-in with T4 DNA polymerase and CIP treated.
- pMON 96001 FIG. 8
- pMON 96010 FIG.
- the oriV in pMON 87488 was removed with Afel and Xhol, the vector was filled-in with T4 DNA polymerase and inserted with the 4.2 kb oriRi replicon from pMON 83934 obtained by digesting pMON 83934 with Pm1I and BstZ17I, resulting into pMON 96001 .
- the 5.6 kb oriRi replicon from pCGN 1589 obtained by digesting it with Dral digestion was inserted to yield pMON 96010 .
- Transformation of soybean cells and regeneration of the cells into intact fertile plants by Agrobacterium -mediated transformation can be conducted using various methods known in the art.
- a method for soybean transformation e.g. U.S. Pat. Nos. 6,384,301 and 7,002,058 was utilized with an organogenesis process.
- the DNA constructs described in the present invention are transformed into a disarmed Agrobacterium strain ABI.
- the two oriV control vectors, pMON 67438 and pMON 83898 (same GOI but in different orientations), were also transferred into Agrobacterium cells.
- Two T DNA constructs and respective controls as described above were also used for transforming soybean.
- the DNA construct was transferred into Agrobacterium by electroporation.
- Single colonies were recovered on LB medium with spectinomycin 50 mg/1 (for oriRi vectors) or 75 mg/1 (for oriV vectors) and kanamycin 50 mg/l and inoculated in 20-50 ml liquid LB medium with same selection in a shaker with 200 rpm.
- the plasmid in the Agrobacterium was verified by restriction enzyme digestion of mini-prepared plasmid from 10 ml culture. The remainder of the liquid culture was mixed with glycerol to a final concentration of 20%, aliquoted and stored at -80 C as seed cultures.
- Soybean cultivar A3525 was used for Agrobacterium-mediated transformation as described (e.g. U.S. Pat. No. 7,002,058). Soybean seeds were germinated for less than 14 hours at room temperature in BGM medium and the meristem explants from soy mature seeds were excised by machine as described in the U.S. Patent Application 20050005321.
- For batch sonication about 100 explants in PLANTCON lid were mixed with 20 ml of the Agrobacterium suspension in INO medium and sonicated in W-113 Sonicator for 20 seconds.
- For bulk sonication about 1000 explants in plantcon lid were mixed with 100 ml of the Agrobacterium suspension in INO medium and sonicated for 20 seconds.
- the explants were co-cultured in the same PLANTCON for 2-4 days at 23° C. with 16/8 hour light/dark period. Then the explants were transferred onto the surface of the WPM selection medium with 75 ⁇ M glyphosate. Each PLANTCON contained about 50 explants. After 2 weeks, explants were transferred again to 75 uM glyphosate solid WPM medium with primary radicle inserted in medium, each PLANTCON containing about 25 explants. Shoots with fully expanded trifolia recovered after 6-10 weeks post-inoculation were rooted in BRM medium with IAA 0.1 mg/l and 25 ⁇ M glyphosate selection. The rooted plantlets were transferred to greenhouse for maturity. Various media used for soybean transformation is detailed below in Table 1.
- the above transformation and regeneration methods provides for plants that are greatly reduced in the occurrence of vector backbone DNA. Additionally, the plants have an added benefit of having reduced copy number of the insert T-DNA.
- the plants produced by the method are an aspect of the invention.
- Agrobacterium containing the vector in glycerol stock was streaked out on solid LB medium supplemented with antibiotics (all in active ingredient) kanamycin (40 mg/L), spectinomycin (31 mg/L), streptomycin (38 mg/L) and chloramphenicol (25 mg/L) and incubated at 28° C. for 2 days. Two days before Agrobacterium inoculation of the maize immature embryos, one colony or a small loop of Agrobacterium from the Agrobacterium plate was picked up and inoculated into 25 mL of liquid LB medium supplemented with 62 mg/L of spectinomycin and 40 mg/L of kanamycin in a 250 mL flask.
- the flask was placed on a shaker at approximately 150-200 rpm and 27-28° C. overnight.
- the Agrobacterium culture was then diluted (1 to 5) in the same liquid medium and put back on the shaker.
- the Agrobacterium cells were spun down at 3500 rpm for 15 min.
- the bacterium cell pellet was re-suspended in induction broth with 200 ⁇ M of acetosyringone and 50 mg/L spectinomycin and 25 mg/L kanamycin and the cell density was adjusted to 0.2 at OD 660 .
- the bacterium cell culture 50 mL in each 250 mL flask) was then put back on the shaker and grown overnight.
- the bacterium cells were spun down and washed with liquid 1 ⁇ 2 MS VI medium (Table 2) supplemented with 200 ⁇ M of acetosyringone. After one more centrifugation, the bacterium cell pellet is re-suspended in 1 ⁇ 2 MS PL medium (Table 2) with 200 ⁇ M of acetosyringone (Table 2) and the cell density was adjusted to 1.0 at OD 660 for inoculation.
- Reagents are commercially available and can be purchased from a number of suppliers (see, for example Sigma Chemical Co., St. Louis, Mo.).
- Corn line LH244 (U.S. Pat. No. 6,252,148) was used in this study. Ears containing immature embryos were harvested and kept refrigerated at 4° C. until use. Immature embryos were isolated from surface sterilized ears and directly dropped into the prepared
- the embryos were transferred onto a modified MS medium (Induction MS, Table 2) supplemented with 500 mg/L carbenicillin and 0.1mM glyphosate at 30° C. for 2 weeks followed by an additional week in a dark culture room at 27-28° C. All the callus pieces were then transferred individually onto the first regeneration medium, the same medium mentioned above except 2,4-D and picloram were replaced by 3.5 mg/L BAP (MS/6BA, Table 2) and the carbenicillin level was dropped to 250 mg/L. The cultures were moved to a culture room with 16-h light/8-h dark photoperiod and 27° C. After 5-7 days, the callus pieces were transferred onto the second regeneration medium (MSOD, Table 2).
- MSOD second regeneration medium
- the callus pieces that had shoots regenerated were transferred onto the same hormone-free medium in PhytatraysTM for further growth.
- Regenerated plants (RO) with one or more healthy roots were moved to soil in peat pots in a growth chamber.
- RO Regenerated plants
- 7 to 10 days they were transplanted into 12-inch pots and moved to a greenhouse with conditions for normal corn plant growth.
- the plants were either self-pollinated or crossed with wild-type plants.
- DNA was extracted from tissue samples collected from greenhouse grown plants transformed with the DNA plasmids of the present invention.
- a PCR-based method was used to assay the DNA for the presence of the oriRi sequence using repA forward primer 5ACAAGGTAGAATCCGCCTGAG-3′ (Xd487b; SEQ ID NO:11) and repA reverse primer 5-TTCAACTCTGGCATCTCAGAC-3′ (Xd488; SEQ ID NO:12) as an indicator of vector backbone.
- This DNA is adjacent to the LB and its presence in the DNA extracted from the regenerated plants indicates that transfer of vector sequences beyond the LB has occurred.
- DNA can be isolated from plant tissues by any number of methods for example, the CTAB procedure (Rogers et al., 1985) or DNAeasyTM 96 Plant Kit (Cat. # 69181, Qiagen Inc., Valencia, Calif.) following the manufacturers instructions.
- Taqman® PE Applied Biosystems, Foster City, Calif.
- DNA primer molecules SEQ ID NO:11 and 12 were used in the described method to identify the oriRi DNA from plant extracts. The conditions and apparatus used can be modified by those skilled in the art to provide the same results.
- Soybean meristem axis excised from mature seeds were transformed with a control DNA plasmid (pMON 67438 or pMON 83898 ) and a plasmid of the present invention (pMON 83882 or pMON 83937 ), then regenerated into intact plants.
- the intact plants were analyzed for the presence of the gene of interest (CP4) and non T-DNA oriRi and oriV sequences. Table 3 shows the results of this analysis.
- transgenic plant Another important component of a commercially viable transgenic plant is the occurrence of low insert complexity. This is often referred to as “low copy number.” It is difficult to select progeny and to successfully breed the transgenic trait if the copy number of the insert is too high. Ideally, only a single copy of the transgene would be present in a transgenic event.
- Copy number can be determined by several methods known in the art of molecular biology. Southern blot analysis is the most commonly used method. Methods using the Invader® technology (Third Wave Inc. Madison, Wis.) are also used for determining copy number of T-DNA inserts in transgenic plants.
- the soybean plant cells were transformed with a control DNA plasmid (pMON 67438 ) and a plasmid of the present invention (pMON 83882 ), then regenerated into intact plants, as described above.
- the resulting transgenic plants were analyzed for copy number using two different methods: 1) “Invader CP4” method and 2) Southern blotting. The results are shown in Table 3.
- the inventive plasmid, pMON 83882 resulted in single-copy transformation events 41% of the time, as compared to the control plasmid pMON 67438 which resulted in a single-copy transformation event only 25% of the time using pooled samples of other experiments or only 37% of the time using side by side experiments.
- pMON 83882 resulted in said events 79.5% of the time, as compared to 60% from side by side experiments and 63% from pooled samples employing the control plasmid.
- pMON 83882 produced one-copy events 56.4% of the time and 33.3% of the time two-copy events, for a total of nearly 90% one- and two-copy events combined. Again, these results were both dramatic and unexpected.
- the 4.2 kb oriRi 2T vector pMON 96001 was side by side compared with the oriV 2T vector pMON 87488 for six times.
- the 5.6 kb oriRi 2T vector pMON 96010 was also included in the last two comparison experiments in these preliminary experiments (Table 4, Group A). Total DNA was extracted from seed segments of mature seeds harvested from greenhouse and used to determine transgene copy number by Invader technology using CP4 probe and NOS probes.
- CP 4 Invader® detection assay used the following sequence as a targeting site: 5′ TCGCTTTCCTTGACGCGGAGTTCTTCCA GACCGTTCAT CACGG 3′ (SEQ ID NO: 13) and GTAGGTGATTGGCGTTG (SEQ ID NO:14) as a probe sequence.
- NOS Invader® detection assay used the following nos 3′ sequence as a targeting site TGAATTACGTTAAGCATGTAATAATTAACATGTAATGCATGACT (SEQ ID NO:15 and GTTATTTATGAGATGGGTTTTTATGA (SEQ ID NO:16) as NOS Invader® probe sequence.
- the 1 and/or 2 copy transformants were increased from 35% in the control oriV vector to over 40% in both oriRi vectors.
- the frequency of marker-free plants in RO plants was increased from 4.76% in the oriV control vector to 16.4% and 18.4%, respectively, in the two oriRi vector.
- the marker-free transformation frequency (marker free events/initial explant number) more than doubled in the two oriRi 2T vectors compared to the oriV 2T vector.
- the oriRi replication origin effect on corn transformation was compared to the oriV vector pMON 92726 with the same T-DNA structure containing gus and CP4 genes.
- Corn immature embryos from Cultivar LH244 were inoculated with Agrobacterium containing either the oriRi or the oriV vector in parallel. Each treatment consisted of about 110 embryos. In total 16 side by side comparison experiments were initiated.
- the oriRi vector showed significantly lower transformation frequency than the oriV control vector ( FIG. 10 ) with average TF 9.5% and 16.3% for oriRi and oriV vectors, respectively. However, the overall transformation efficiency with oriRi and oriV vectors was same.
- backbone sequence in transgenic corn plants was determined by Endpoint TaqMan® assay (Applied Biosystems, Foster City, Calif).for the oriRi or oriV sequence, LB sequences that are 3′ flanking for short read-through close to the LB nicking site and RB sequences that are 5′ flanking before the RB nicking site for intact backbone readthrough.
- the oriRi primers are 5′ TGGCAAGGAATGGGTTTGAG 3′ (forward; SEQ ID NO:20) and 5′ CTACAACTACAGGCGCTGCTTTT 3′ (reverse; SEQ ID NO:21) with the probe 6-FAM-TGGCGAAGTCTGTCC (SEQ ID NO:22) to detect oriRi sequence 621 bp downstream of LB nicking site.
- the RB 5′ flanking primers are 5′ GCCAAGGGATCTTTTTGGAAT 3′ (forward; SEQ ID NO:23) and 5′ CCACCCAAACGTCGGAAA 3′ (reverse; SEQ ID NO:24) with the probe 6FAM-TGCTCCGTCGTCAGG (SEQ ID NO:25) to detect 5′ RB flanking 186 bp before the RB nicking site.
- the primers for detecting LB 35 bp downstream of the LB nicking site were 5′ GCACCCGGTGGAGCTT 3′ (forward; SEQ ID NO:26) and 5′ TCTGCCTAACCGGCTCAGT 3′ (reverse; SEQ ID NO:27) with the probe CATGTTGGTTTCTACGCAG (SEQ ID NO:28) labeled with fluorescent dye 6-FAM at the 5′ end.
- the CP4 transgene copy number was determined by Invader® assay according to the manufacturer's instruction (Third Wave Technologies Inc. Madison, Wis.) using the a CP4 sequence.
- the gus transgene copy number was measured by determining the gus cassette transcriptional terminator pinII (shown as Pis 4 in FIGS. 5 and 6 ) using TaqMan® technology (Applied Biosystems, Foster City, Calif.).
- the pinII TaqMan® primers were 5′ ATGAAATAAAAGGATGCACACAT 3′ (forward; SEQ ID NO:29) and 5′ ACAACTTTGATGCCCACATT 3′ (reverse; SEQ ID NO:30) with the probe TGACATGCTAATCAC- (SEQ ID NO:31) labeled with fluorescent dyes 6-FAM at the 5′ end and MGBNFQ at the 3′ end.
- FIG. 12 shows the transgene copy number assay results.
- the oriRi vector significantly increased single copy plant frequency compared to the control oriV vector, while the frequency of 2 or more copy events in oriRi vector was decreased.
- Both TaqMan® and Invader® assays with two different probes showed similar results. Since the single copy backbone free plants are the most valuable for both research and development, the oriRi vector increasing the single copy frequency and decreasing backing containing events in corn represents a significant improvement for quality in transgenic event production.
- the repABC fragment was digested with Pm11 and AvrII (shown by underlined sequence in primers) and ligated to pMON 96948 opened with Smal and AvrII.
- the ligate was directly transferred into Agrobacterium tumefaciens AB2 (a kanamycin sensitive strain) competent cells, and plated onto LB plate with kanamycin 50 mg/l.
- the kan resistant colonies were inoculated into liquid LB medium with 50 mg/l kanamycin, and a plasmid DNA was prepared by miniprep.
- the construct was confirmed by restriction digestion. Since the vector pMON 96951 does not contains an E. coli replication origin, it can not be maintained in E. coli.
- pMON 96951 ( FIG. 13 ) is used for transforming plant species as described above.
- the transgenic events are analyzed for reduced vector backbone integration and high frequency of low-copy transformation events by methods described in Example 4.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
- This application claims the priority of U.S. provisional application Ser. No. 60/714,501, filed Sep. 6, 2005, the entire contents of which are incorporated by reference herein.
- The invention relates generally to the field of molecular biology. More specifically, the invention relates to improved methods for plant genetic transformation and compositions for achieving the same.
- Transformation of plant cells by an Agrobacterium-mediated method involves exposing plant cells and tissues to a suspension of Agrobacterium cells that contain certain DNA plasmids. These plasmids have been specifically constructed to contain transgenes that will express in plant cells (see, for example, U.S. Pat. No. 5,034,322). Most often, one or more of the transgenes is a positive selectable marker transgene that permits plant cells to grow in the presence of a positive selection compound, such as an antibiotic or herbicide. These cells can be further manipulated to regenerate into whole fertile plants.
- The methods for introducing transgenes into plants by an Agrobacterium-mediated transformation method generally involve a T-DNA (transfer DNA) that incorporates the genetic elements of at least one transgene and transfers those genetic elements into the genome of a plant. The transgene(s) are typically constructed in a DNA plasmid vector and are usually flanked by an Agrobacterium Ti plasmid right border DNA region (RB) and a left border DNA region (LB). During the process of Agrobacterium-mediated transformation, the DNA plasmid is nicked by an endonuclease, VirD2, at the right and left border regions. A single strand of DNA from between the nicks, called the T-strand, is transferred from the Agrobacterium cell to the plant cell. The sequence corresponding to the T-DNA region is inserted into the plant genome.
- The integration of the T-DNA into the plant genome generally begins at the RB and continues to the end of the T-DNA, at the LB. However, the endonucleases sometimes do not nick equally at both borders. When this happens, the T-DNA that is inserted into the plant genome often contains some or all of the plasmid vector DNA. This phenomenon is referred to as “border read-through.” It is usually preferred that only the transgene(s) located between the right and left border regions (the T-DNA) is transferred into the plant genome without any of the adjacent plasmid vector DNA (the vector backbone). The vector backbone DNA contains various plasmid maintenance elements, including for example, origin of replications, bacterial selectable marker genes, and other DNA fragments that are not required to express the desired trait(s) in commercial crop products.
- Considerable resources are directed at screening the genome of transgenic crop plants for the presence the vector backbone DNA. Methods such as polymerase chain reaction (PCR) and Southern blot analysis are most often employed to identify the extraneous vector backbone DNA. These methods are time consuming and expensive for large-scale screening work. The transgenic plants that are found to contain vector backbone DNA are generally not preferred for commercialization. Further, transgenic plants containing more than two transgenes are usually of little value for commercial development. Substantial efforts are expended regenerating plants from plant cell culture that have no commercial potential.
- Thus, it would be of great benefit if methods and compositions could be developed that would greatly reduce the occurrence of vector backbone DNA in the genome of transgenic plants and/or increase the frequency of low copy transformation events. Fewer transgenic plants would have to be produced if a greater number were free from vector backbone DNA and most plants have one or two copies of the transgenes, greatly increasing the efficiency of transgenic plant production.
- In accordance with one aspect of the invention, constructs and methods are provided for improving the quality of events in bacterially-mediated plant cell transformation, such as Agrobacterium-mediated plant transformation. The invention is advantageous in providing a reduced frequency of vector backbone DNA, i.e., non-T-DNA region, transformation events and of increasing the frequency of T-DNA transformation events with one or two copies of the T-DNA.
- The invention also provides DNA constructs for transforming plants comprising: i) at least one T-DNA border region; ii) at least one heterologous transgene adjacent to the border region; iii) a coding region for a bacterial selectable marker; and iv) at least one segment of DNA, comprising a cis and/or trans element or elements of a replication origin for maintaining a low copy number of the DNA construct in a plant cell transforming bacterium.
- In certain embodiments of the invention, the elements of the replication origin for maintaining low copy number of a DNA construct in a plant cell transforming (plant cell transformation competent) bacterial cell comprise one or more of repA (e.g. SEQ ID NO:32 or SEQ ID NO:38); repB (e.g. SEQ ID NO:33 or SEQ ID NO:39); repC (e.g. SEQ ID NO:34 or SEQ ID NO:40); igsl (e.g. SEQ ID NO:35 or SEQ ID NO:41); igs2 (e.g. SEQ ID NO:36 or SEQ ID NO:42). A construct may also optionally include a palindromic sequence, for example, the 16 bp palindromic sequence of SEQ ID NO:37. These elements may be arranged in cis or in trans with respect to each other.
- In some embodiments, the a T-DNA border region is defined as a right border region (RB) or a left border (LB) region. Further, in certain embodiments the RB and/or LB sequences comprise SEQ ID NO:43 or SEQ ID NO:44. In particular embodiments, a heterologous transgene when expressed in a transformed plant cell provides an agronomic phenotype to the cell or transformed plant derived from the cell. In further embodiments, a coding region for a bacterial selectable marker is an antibiotic resistance gene selected from kanamycin resistance gene, gentamycin resistance gene, chloramphenicol resistance gene, spectinomycin resistance gene, streptomycin resistance gene, tetracycline resistance gene, ampicillin resistance gene, blasticidin resistance gene, hygromycin resistance gene, puromycin resistance gene, or Zeocin resistance gene.
- In some embodiments, a replication origin comprises a repABC sequence selected from SEQ ID NOs: 1, 2, 3, or 4. In one embodiment, the at least one segment of DNA comprises replication genes repA, repB, and repC. In some embodiments, the at least one segment of DNA comprises intergenic sequence 1 (igs1) and intergenic sequence 2 (igs2). In some embodiments, the at least one segment of DNA comprises a 16 base pair palindromic sequence. In other embodiments the segment of DNA comprises all sequences of repABC necessary for maintaining low copy number (1-3 copies per cell) in Agrobacterium or other plant cell transforming competent bacteria. Constructs containing repABC and methods or their use are described in more detail below.
- The DNA constructs of the present invention may be transferred to any cell, for example, such as a plant cell transformation competent bacterium. Such bacteria are known in the art and may, for instance, belong to the following species: Agrobacterium spp., Rhizobium spp., Sinorhizobium spp., Mesorhizobium spp., Phyllobacterium spp. Ochrobactrum spp. and Bradyrhizobium spp. Preferably, such bacteria may belong to Agrobacterium spp. The DNA constructs of the present invention may further comprise one or more replication origins for maintaining copies of the construct in E. coli. In some embodiments, origin of replication for maintaining copies of the construct in E. coli is derived from at least one of pBR322 and pUC.
- The present invention also relates to a plant cell transforming bacterium comprising the DNA construct of the present invention, and which may be used for transforming a plant cell. In some embodiments, the plant transforming bacteria is selected from Agrobacterium spp., Rhizobium spp., Sinorhizobium spp., Mesorhizobium spp., Phyllobacterium spp. Ochrobactrum spp. or Bradyrhizobium spp.
- The present invention also relates to a method for transforming a plant cell comprising: contacting at least a first plant cell with a plant cell transforming bacteria of the present invention; and selecting at least a plant cell transformed with at least one heterologous transgene. In some embodiments, the plant cell is a soybean, canola, corn, or cotton plant cell. In one embodiment, a method of the invention further comprises regenerating a plant from the plant cell.
- The present invention also relates to a method of producing food, feed or an industrial product comprising: obtaining the plant of the present invention or a part thereof; and preparing the food, feed or industrial product from the plant or part thereof.
- The invention also includes methods of genetically transforming plants with the DNA constructs of the present invention and reducing the frequency of plants transformed with non-T DNA vector region In some embodiments, the frequency of plants transformed with non-T-DNA region may be defined as less than or equal to about 20%. In some embodiments, the frequency is less than or equal to about 15%, in some embodiments less than about 10%, and in some embodiments less than or equal to about 8% or 5%. In some embodiments of the methods of the invention, the frequency of one- or two-copy T-DNA transformation events obtained is greater than or equal to about 70% or 75%. In some instances, that frequency can be raised to greater than or equal to about 80% or 85%, and in some embodiments, to greater than about 90% or 95%.
- In addition to a full length oriRi, the present invention encompasses plant transformation vectors containing mutants and variants of oriRi that retain substantially similar function to the full length sequence when used in the present invention. For example, applicants have identified the truncated sequence disclosed in SEQ ID NO: 3 that is suitable for use in the present invention. One of skill in the art can readily make additional changes, deletions, substitutions, etc in the oriRi sequence and screen for functional activity using the methods of the present invention. Thus, the present invention encompasses such variants and mutants.
- Additional features and advantages of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The features and advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
- It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
- The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate different embodiments of the invention and together with the description, serve to explain the principles of the invention.
- Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for describing particular embodiments only and is not intended to be limiting of the invention. As used in the description of the invention and the appended claims, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.
-
FIG. 1 shows a plasmid map of pMON83856, the base vector with a 5.6 kb oriRi fragment used for construction of pMON83882 for soybean transformation and pMON97352 for corn transformation. -
FIG. 2 shows a plasmid map of pMON83882, the testing vector with a 5.6 kb oriRi fragment and 5-enolpyruvylshikimate-3-phosphate synthase (CP4-EPSPS) selectable marker gene and the uidA (gus) gene of interest, as an example, for soy transformation. -
FIG. 3 shows a plasmid map of pMON83934, a base vector with a 4.2 kb oriRi fragment used for construction of pMON83937. -
FIG. 4 shows a plasmid map of pMON83937, a testing vector with a 4.2 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soy transformation. -
FIG. 5 shows a plasmid map of pMON97352, a test vector with a 5.6 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for corn transformation. -
FIG. 6 shows a plasmid map of pMON92726 which was used as a control for corn transformation. It contains the same gene structure as pMON97352 except for the replication origin. It contains ori V instead of oriRi. -
FIG. 7 shows a plasmid map of pMON87488, a 2 T-DNA transformation vector, which was used as a control for soybean transformation. It contains ori V instead of oriRi. -
FIG. 8 shows a plasmid map of pMON96001, a 2 T-DNA transformation test vector with a 4.3 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soybean transformation. -
FIG. 9 shows a plasmid map of pMON96010, a 2 T-DNA transformation test vector with a 5.6 kb oriRi fragment and CP4 selectable marker gene and GOI (gus), as an example, for soybean transformation. -
FIG. 10 shows the effect of type of replication origin on transformation frequency in corn. Error bars represent the 95% confidence interval; * indicates a significant difference between oriRi (pMON97352) and oriV (pMON92726). -
FIG. 11 shows the effect of type of replication origin on backbone sequence transfer in corn transformation. Error bars represent the 95% confidence interval; * indicates a significant difference between oriRi (pMON97352) and oriV (pMON92726). oriRi/ori V, RB, and LB indicates the type of backbone probe used. -
FIG. 12 shows the effect of type of replication origin on transgene quality in corn transformation. Error bars represent the 95% confidence interval. 0, 1, 2, 3+indicates copy number. -
FIG. 13 shows a plasmid map of pMON96951 containing repABC replication origin from Rhizobium etli CFN42 p42b plasmid and CP4 EPSPS selectable marker gene for soybean. - The invention will now be described by reference to more detailed embodiments, with occasional reference to the accompanying drawings. This invention may, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are illustrative and provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
- The present invention relates, in part, to the discovery that the repABC origin of replication, such as the one from Agrobacterium rhizogenes pRi (“oriRi” or “oriPRi”), which maintains 1-3 copies in bacteria such as Agrobacterium, can be used in plant transformation vectors and can impart highly desirable transformation events. The vectors of the invention can, for example, significantly reduce the frequency of transformation events that transfer non-T-DNA region, i.e., vector backbone DNA, and can, for example, significantly increase the number of one- or two-copy T-DNA, i.e., the gene of interest, transformation events. The prior art does not teach or suggest the use of oriRi to achieve these unexpected transformation results. The vectors and methods of the invention improve transformation events in the preparation of transgenic crop plants.
- As used herein, a transgenic crop plant contains an exogenous polynucleotide molecule or a heterologous transgene inserted into the genome of a crop plant cell. A crop plant cell, includes without limitation, a plant cell, and further comprises suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, ovules, pollen and microspores, and seeds, and fruit. By “exogenous” or “heterologous” it is meant that a polynucleotide molecule which originates from outside the plant cell into which the polynucleotide molecule is introduced. An exogenous polynucleotide molecule can have a naturally occurring or non-naturally occurring nucleotide sequence. One skilled in the art understands that an exogenous polynucleotide molecule can be a heterologous molecule derived from a different species of any other organism or the plant species than the plant into which the polynucleotide molecule is introduced or can be a polynucleotide molecule derived from the same plant species as the plant into which it is introduced.
- The exogenous polynucleotide (heterologous transgene) when expressed in a transformed plant cell provides an agronomic trait to the cell or to a transformed plant derived from the cell. These genes of interest (GOI) provide beneficial agronomic traits to crop plants, for example, including, but not limited to genetic elements comprising herbicide resistance (U.S. Pat. Nos. 5,633,435; 5,463,175), increased yield (U.S. Pat. No. 5,716,837), insect control (U.S. Pat. Nos. 6,063,597; 6,063,756; 6,093,695; 5,942,664; 6,110,464), fungal disease resistance (U.S. Pat. Nos. 5,516,671; 5,773,696; 6,121,436; and U.S. Pat. Nos. 6,316,407; 6,506,962), virus resistance (U.S. Pat. No. 5,304,730 and U.S. Pat. No. 6,013,864), nematode resistance (U.S. Pat. No. 6,228,992), bacterial disease resistance (U.S. Pat. No. 5,516,671), starch production (U.S. Pat. No. 5,750,876 and U.S. Pat. No. 6,476,295), modified oils production (U.S. Pat. No. 6,444,876), high oil production (U.S. Pat. No. 5,608,149 and U.S. Pat. No. 6,476,295), modified fatty acid content (U.S. Pat. No. 6,537,750), high protein production (U.S. Pat. No. 6,380,466), fruit ripening (U.S. Pat. No. 5,512,466), enhanced animal and human nutrition (U.S. Pat. No. 5,985,605 and U.S. Pat. No. 6,171,640), biopolymers (U.S. Pat. No. 5,958,745 and U.S. Patent Pub 2003/0028917), environmental stress resistance (U.S. Pat. No. 6,072,103), pharmaceutical peptides (U.S. Pat. No. 6,080,560), improved processing traits (U.S. Pat. No. 6,476,295), improved digestibility (U.S. Pat. No. 6,531,648) low raffinose (U.S. Pat. No. 6,166,292), industrial enzyme production (U.S. Pat. No. 5,543,576), improved flavor (U.S. Pat. No. 6,011,199), nitrogen fixation (U.S. Pat. No. 5,229,114), hybrid seed production (U.S. Pat. No. 5,689,041), and biofuel production (U.S. Pat. No. 5,998,700), the genetic elements and transgenes described in the patents listed above are herein incorporated by reference.
- The present invention provides plant recombinant DNA constructs for producing transgenic crop plants. Methods that are well known to those skilled in the art may be used to prepare the crop plant recombinant DNA construct of the present invention. These methods include in vitro recombinant DNA techniques, synthetic techniques, and in vivo genetic recombination. Such techniques are described in Sambrook et al. (1989). Exogenous polynucleotide molecules created by the methods may be transferred into a crop plant cell by a plant transforming bacterium such as Agrobacterium or by other methods known to those skilled in the art of plant transformation. Gene transfer to plants has been shown using diverse species of bacteria as described in Broothaerts et al. (2005) and the U.S.
provisional application 60/800,872, herein incorporated by reference. The recombinant DNA constructs of the present invention may be transferred into a crop plant cell by transformation using Sinorhizobium meliloti, Rhizobium sp., Mesorhizobium loti, or any other bacterium capable of transforming a plant cell. - The invention includes plant transformation vectors for use in Agrobacterium-mediated transformation of plants. The vectors of the present invention are generally plasmids, but the oriRi replication origin may be replaced by other replication origins from the repABC family for maintaining very low copy number (1-3 copies per cell) in Agrobacterium. Also, vectors without an Agrobacterium-maintaining replication origin are capable of maintaining themselves in Agrobacterium with sequences in the T-DNA that can be integrated into either the Ti plasmid in A. tumefaciens, Ri plasmid in A. rhizogenes or Agrobacterium chromosome through homologous recombination. This results in the same effect of a reduction in non T-DNA sequence insertion and an increase in low copy number transformation events, since the chromosome, Ti or Ri plasmid is present in a single copy. When Rhizobia or non Agrobacterium species are used for plant transformation, T-DNA containing GOI can be integrated into the chromosome or into repABC plasmids in the host bacteria, which can produce the same effect as Agrobacterium does.
- A vector of the present invention may comprise at least one of Agrobacterium Ti plasmid right border or left border region. The vectors may comprise at least one pair of borders. The vectors can include four pairs of borders, but the vector often comprise one or two pairs.
- The vectors of the present invention may further comprise a coding region for a selectable marker for the maintenance in bacterial hosts. Coding regions for selectable markers include Spec/Strp that encodes for Tn7 aminoglycoside adenyltransferase (aadA) conferring resistance to spectinomycin or streptomycin, or a gentamycin (Gm, Gent) selectable marker gene. Other resistance genes include carbenecillin, ampicillin, and kanamycin resistance genes. Others are known and may be readily used in the present invention by those of skill in the art.
- The vectors of the present invention may also comprise a coding region for a plant selectable marker gene, which is typically located in T-DNA, to select transformed plant cells with the corresponding reagent. The plant selectable marker may provide resistance to a positive selection compound, for example, antibiotic resistance (e.g., kanamycin, G418, bleomycin, hygromycin, etc.), or herbicide resistance (e.g., including but not limited to: glyphosate, Dicamba, glufosinate, sulfonylureas, imidazolinones, bromoxynil, dalapon, cyclohexanedione, protoporphyrinogen oxidase inhibitors, and isoxaflutole herbicides). Polynucleotide molecules encoding proteins involved in herbicide tolerance are known in the art, and include, but are not limited to a polynucleotide molecule encoding a) tolerance to a glyphosate include 5-enolpyruvylshikimate-3-phosphate synthases (EP SPS; U.S. Pat. Nos. 5,627,061, 5,633,435, 6,040,497, 5,094,945, WO04074443, and WO04009761), glyphosate oxidoreductase (GOX; U.S. Pat. No. 5,463,175), glyphosate decarboxylase (WO05003362 and U.S. Patent Application 20040177399), and glyphosate-N-acetyl transferase (GAT; U.S. Patent publication 20030083480) conferring tolerance to glyphosate; b) dicamba monooxygenase (DMO, encoded by ddmC) conferring tolerance to auxin-like herbicides such as dicamba (U.S. Patent Applications 20030115626, 20030135879; Herman et al., 2005); c) phosphinothricin acetyltransferase (bar) conferring tolerance to phosphinothricin or glufosinate (U.S. Pat. Nos. 5,646,024, 5,561,236, EP 275,957; U.S. Pat. Nos. 5,276,268; 5,637,489; 5,273,894); d) 2,2- dichloropropionic acid dehalogenase conferring tolerance to 2,2-dichloropropionic acid (Dalapon) (WO9927116); e) acetohydroxyacid synthase or acetolactate synthase conferring tolerance to acetolactate synthase inhibitors such as sulfonylurea, imidazolinone, triazolopyrimidine, pyrimidyloxybenzoates and phthalide (U.S. Pat. Nos. 6,225,105; 5,767,366, 4,761,373; 5,633,437; 6,613,963; 5,013,659; 5,141,870; 5,378,824; 5,605,011); f) haloarylnitrilase (Bxn) for conferring tolerance to bromoxynil (WO8704181A1; U.S. Pat. No. 4,810,648; WO8900193A); g) modified acetyl-coenzyme A carboxylase for conferring tolerance to cyclohexanedione (sethoxydim) and aryloxyphenoxypropionate (haloxyfop) (U.S. Pat. No. 6,414,222); h) dihydropteroate synthase (sull) for conferring tolerance to sulfonamide herbicides (U.S. Pat. Nos. 5,597,717; 5,633,444; 5,719,046); i) 32 kD photosystem II polypeptide (psbA) for conferring tolerance to triazine herbicides (Hirschberg et al., 1983); j) anthranilate synthase for conferring tolerance to 5-methyltryptophan (U.S. Pat. No. 4,581,847); k) dihydrodipicolinic acid synthase (dapA) for conferring to tolerance to aminoethyl cysteine (WO8911789); 1) phytoene desaturase (crtl) for conferring tolerance to pyridazinone herbicides such as norflurazon (JP06343473); m) hydroxy-phenyl pyruvate dioxygenase for conferring tolerance to cyclopropylisoxazole herbicides such as isoxaflutole (WO 9638567; U.S. Pat. No. 6,268,549); n) modified protoporphyrinogen oxidase I (protox) for conferring tolerance to protoporphyrinogen oxidase inhibitors (U.S. Pat. No. 5,939,602); and o) aryloxyalkanoate dioxygenase (AAD-1) for conferring tolerance to an herbicide containing an aryloxyalkanoate moiety (WO05107437). Examples of such herbicides include phenoxy auxins (such as 2,4-D and dichlorprop), pyridyloxy auxins (such as fluroxypyr and triclopyr), aryloxyphenoxypropionates (AOPP) acetyl- coenzyme A carboxylase (ACCase) inhibitors (such as haloxyfop, quizalofop, and diclofop), and 5- substituted phenoxyacetate protoporphyrinogen oxidase IX inhibitors (such as pyraflufen and flumiclorac).
- In addition to a plant selectable marker, in some embodiments it may be desirable to use a reporter gene. In some instances, a reporter gene may be used with or without a selectable marker. Reporter genes are genes that are typically not present in the recipient organism or tissue and typically encode for proteins resulting in some phenotypic change or enzymatic property. Examples of such genes are provided in Wising et al. (1988), that is incorporated herein by reference. Preferred reporter genes include the beta-glucuronidase (GUS) of the uidA locus of E. coli, the chloramphenicol acetyl transferase gene from Tn9 of E. coli, the green fluorescent protein from the bioluminescent jellyfish Aequorea victoria, and the luciferase genes from firefly Photinus pyralis. An assay for detecting reporter gene expression may then be performed at a suitable time after said gene has been introduced into recipient cells. A preferred such assay entails the use of the gene encoding beta-glucuronidase (GUS) of the uidA locus of E. coli as described by Jefferson et al. (1987) to identify transformed cells, referred to herein as GUS.
- In some embodiments, the vectors of the present invention comprise one replication origin for maintenance in E. coli. These origins of replication may be derived, for example, from pBR322 or from pUC. One example of such an origin of replication is ColE1. The vectors of the present invention can include any origin of replication which maintains at least 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, or 100 or more plasmid copies in E. coli. In some embodiments, the ori maintains a higher copy number in E. coli (e.g., greater than 5, 10, 15, 20, 25, or 30, and in some further embodiments, greater than 10, 15, 20, 25 or 30). Such high copy number vectors make it easier to amplify the amount of DNA available for transformation. Thus, in some embodiments, the present invention includes a vector containing an ori that provides high copy numbers in E. coli cells, and a second ori, such as an ori belonging to the repABC family, for example, oriRi, that maintains extremely low copy number, for example 1-3, in Agrobacterium.
- The vectors of the present invention also comprise at least one segment of DNA, comprising cis and/or trans elements, which is necessary and sufficient for low-copy plasmid maintenance (1-3 copies) in a plant transforming bacterium such as Agrobacterium. The at least one segment of DNA preferably comprises an origin of replication from the repABC family. Further, the at least one segment of DNA may include a Ri plasmid replication origin of Agrobacterium rhizogenes (oriRi) and/or repABC origin from plasmid p42b of Rhizobium etli. Still further, the repABC family preferably comprises replication genes repA, repB, and repC. The at least one segment also may comprise intergenic region sequences, igs1 and igs2. Still further, the at least one segment of DNA may include a 16-bp palindrome after repC.
- As used herein, the “origin of replication” of a “repABC” plasmid, i.e. a plasmid that utilizes such sequences for replication and partitioning in a cell, may be defined as comprising repA (e.g. SEQ ID NO:32 from pRi of A. rhizogenes; SEQ ID NO:38 from p42b of R. etli), repB (e.g. SEQ ID NO: SEQ ID NO:33 from A. rhizogenes; SEQ ID NO:39 from p42b of R. etli), repC (e.g. SEQ ID NO: SEQ ID NO:34 from A. rhizogenes; SEQ ID NO:40 from p42b of R. etli),igsl (e.g. SEQ ID NO:35 from A. rhizogenes; SEQ ID NO:41 from p42b of R. etli)), igs2 (e.g. SEQ ID NO:36 from A. rhizogenes; SEQ ID NO:42 from p42b of R. etli), and may optionally comprise a palindromic sequence (e.g. SEQ ID NO:37). In other embodiments, the origin of replication may comprise those sequences required for maintaining low copy number (for example, from 1 to about 3 copies) within a plant-cell-transforming bacterial cell. Examples of such repABC origins of replication are found in SEQ ID NOs:1-4, in the oriRi of the Ri plasmid of A. rhizogenes, and in plasmid p42b of R. etli, among others.
- In one embodiment, the at least one segment is as identified in SEQ ID NO:1. In other embodiments, the at least one segment consists essentially of the following sequence: 5618 bp oriRi of pMON83882 bases (633-6250) identified as SEQ ID NO:2. In another embodiment, the at least one segment comprises and/or consists essentially of the sequence identified in SEQ ID NO:3. In yet another embodiment, the at least one segment may be repABC from p42b from R. etli as identified in SEQ ID NO:4.
- Encompassed within the definition of any of the nucleic acid or polypeptide sequence defined herein are sequences which exhibit a specified degree of identity to such sequences. For example, it should be noted that while specific nucleic acid sequences are set forth herein, modifications may be made to the described sequences without departing from the scope of the invention. In particular, nucleic acid sequences which are substantially identical to those set forth herein may be used with the present invention. A first nucleic acid sequence displays “substantial identity” to a reference nucleic acid sequence if, when optimally aligned (with appropriate nucleotide insertions or deletions totaling less than 20 percent of the reference sequence over the window of comparison) with the other nucleic acid (or its complementary strand), there is at least about 75% nucleotide sequence identity, preferably at least about 80% identity, more preferably at least about 85%, 86%, 87%, 88%, or 89% identity, and most preferably at least about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% identity over a comparison window of at least 200 nucleotide positions, preferably at least 300 nucleotide positions, more preferably at least 400 nucleotide positions, and most preferably over the entire length of the first nucleic acid. Optimal alignment of sequences for aligning a comparison window may be conducted by the similarity method of Pearson and Lipman (1988); preferably by computerized implementations of these algorithms in the Wisconsin Genetics Software Package Release 7.0, Genetics Computer Group, Madison, Wis. The reference nucleic acid may be a full-length molecule or a portion of a longer molecule.
- Alternatively, two nucleic acids have substantial identity if one hybridizes to the other under stringent hybridization conditions. The term “stringent hybridization conditions” is defined as conditions under which a test sequence hybridizes specifically with a target sequence(s) but not with non-target sequences, as can be determined empirically. The term “stringent conditions” is functionally defined with regard to the hybridization of a nucleic-acid probe to a target nucleic acid (i.e., to a particular nucleic-acid sequence of interest) by the specific hybridization procedure (see for example Sambrook et al., 1989, at 9.52-9.55, Sambrook et al., 1989 at 9.47-9.52, 9.56-9.58; Kanehisa, 1984; and Wetmur and Davidson, 1968). Appropriate stringent conditions for DNA hybridization are, for example, 6.0x sodium chloride/sodium citrate (SSC) at about 45° C., followed by a wash of 0.2x SSC at 50° C. Details of such methods are known to those skilled in the art or can be found in laboratory manuals including but not limited to Current Protocols in Molecular Biology (1989). In some embodiments, lower stringency conditions may be used by changing the wash to about 2.0x SSC at 50° C. In addition, the temperature in the wash step can be increased from low stringency conditions at room temperature, about 22° C., to higher stringency conditions at about 65° C. Both temperature and salt may be varied, or either the temperature or the salt concentration may be held constant while the other variable is changed. For example, hybridization using DNA or RNA probes or primers can be performed at 65° C. in 6x SSC, 0.5% SDS, 5x Denhardt's, 100 μg/mL nonspecific DNA (e.g., sonicated salmon sperm DNA) with washing at 0.5x SSC, 0.5% SDS at 65° C., for high stringency.
- A nucleic acid molecule is said to be the “complement” of another nucleic acid molecule if they exhibit complete complementarity. As used herein, molecules are said to exhibit “complete complementarity” when every nucleotide of one of the molecules is complementary to a nucleotide of the other. Two molecules are said to be “minimally complementary” if they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under at least conventional “low stringency” conditions. Similarly, the molecules are said to be “complementary” is they can hybridize to one another with sufficient stability to permit them to remain annealed to one another under conventional “high stringency” conditions. It is contemplated that lower stringency hybridization conditions such as lower hybridization and/or washing temperatures can be used to identify related sequences having a lower degree of sequence similarity if specificity of binding of the probe or primer to target sequence(s) is preserved. Accordingly, the nucleotide sequences of the present invention can be used for their ability to selectively form duplex molecules with complementary stretches of DNA fragments. Detection of DNA segments via hybridization is well-known to those of skill in the art, and thus depending on the application envisioned, one will desire to employ varying hybridization conditions to achieve varying degrees of selectivity of probe towards target sequence and the method of choice will depend on the desired results. Conventional stringency conditions are described in Sambrook, et al. (1989) and by Haymes et al. (1985).
- The DNA construct of the present invention may be introduced into the genome of a desired plant host by a suitable Agrobacterium-mediated plant transformation method. Methods for transforming plants by Agrobacterium tumefaciens-mediated transformation include: Fraley et al., (1985), and Rogers et al., (1987). Agrobacterium-mediated transformation is achieved through the use of a genetically engineered soil bacterium belonging to the genus Agrobacterium. Several Agrobacterium species mediate the transfer of a specific DNA known as “T-DNA,” that can be genetically engineered to carry any desired piece of DNA into many plant species. The major events marking the process of T-DNA mediated pathogenesis are induction of virulence genes, and processing and transfer of the T-strand. This process is the subject of many reviews (Ream, 1989; Howard and Citovsky, 1990; Kado, 1991; Winans, 1992; Zambryski, 1992; Gelvin, 1993; Binns and Howitz, 1994; Hooykaas and Beijersbergen, 1994; Lessl and Lanka, 1994; Zupan and Zambryski, 1995). Non-Agrobacterium species such as Sinorhizobium meliloti, Rhizobium sp., Mesorhizobium loti, may also be used for transferring genes using the DNA constructs of the present invention (Broothaerts et al., 2005 and the U.S.
provisional application 60/800,872, herein incorporated by reference). Other methods for introducing DNA into cells may also be used. These methods are well known to those of skill in the art and can include to chemical methods and physical methods such as microinjection, electroporation, and micro-projectile bombardment. - Plant cell regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, also typically relying on a biocide and/or herbicide marker that has been introduced together with the desired nucleotide sequences. Choice of methodology with suitable protocols being available for hosts from Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, canola/rapeseed, etc.), Cucurbitaceae (melons and cucumber), Gramineae (wheat, barley, rice, maize, etc.), Solanaceae (potato, tobacco, tomato, peppers), various floral crops, such as sunflower, and nut-bearing trees, such as almonds, cashews, walnuts, and pecans. See, for example, Ammirato et al. (1984); Shimamoto et al. (1989); Fromm (1990); Vasil et al., (1990); Vasil et al. (1992); Hayashimoto (1990); and Datta et al. (1990). Such regeneration techniques are described generally in Klee et al. (1987). Methods and compositions for transforming plants by introducing a transgenic DNA construct into a plant genome in the practice of this invention can include any of the well-known and demonstrated methods. For example, Agrobacterium-mediated transformation as illustrated in U.S. Pat. Nos. 5,824,877; 5,591,616; and 6,384,301, all of which are incorporated herein by reference.
- Plants that can be made by practice of the present invention include any plants that are subject to transformation and regeneration and include, but are not limited to, Acacia, alfalfa, aneth, apple, apricot, artichoke, arugula, asparagus, avocado, banana, barley, beans, beet, blackberry, blueberry, broccoli, brussels sprouts, cabbage, canola, cantaloupe, carrot, cassava, cauliflower, celery, Chinese cabbage, cherry, cilantro, citrus, clementines, coffee, corn, cotton, cucumber, Douglas fir, eggplant, endive, escarole, eucalyptus, fennel, figs, forest trees, gourd, grape, grapefruit, honey dew, jicama, kiwifruit, lettuce, leeks, lemon, lime, Loblolly pine, mango, melon, mushroom, nut, oat, okra, onion, orange, an ornamental plant, papaya, parsley, pea, peach, peanut, pear, pepper, persimmon, pine, pineapple, plantain, plum, pomegranate, poplar, potato, pumpkin, quince, radiata pine, radicchio, radish, raspberry, rice, rye, sorghum, Southern pine, soybean, spinach, squash, strawberry, sugarbeet, sugarcane, sunflower, sweet potato, sweetgum, tangerine, tea, tobacco, tomato, turf, a vine, watermelon, wheat, yams, and zucchini. In preferred embodiments, the plant is a soybean, corn, canola, or cotton plant. In particular embodiments, the plant is a corn plant. In particular embodiments, the plant is a soybean plant. In other embodiments, the plant is a cotton plant. And in still further embodiments, the plant is a canola plant.
- The present methods yield improved transformation efficiencies, significantly reducing the frequency of plants transformed with vector backbone DNA, or “non-T-DNA.” In some embodiments, the frequency of plants transformed with non-T DNA is less than or equal to about 20%. In some embodiments, the frequency of plants transformed with non-T DNA is less than or equal to about 15%, or less than equal to about 10%, or less than or equal to about 8% or 5%. Additionally, the methods of the invention yield very high one- or two- copy T-DNA transformation events. For example, in some embodiments, the frequency of one- or two-copy T-DNA transformation events is greater than or equal to about 70% or 75%, as measured using Southern blotting. In some embodiments, that frequency is greater than or equal to about 80% or 85%, and in some cases, 90% or 95%, as measured with Southern blotting.
- In some embodiments, the frequency of plants transformed with non-T DNA vector region is about 50%, 40%, 20%, 15%, or 10% lower than the frequency of T-DNA found in the same variety of plant that has been transformed with a plant transformation vector that does not contain the repABC element such as oriRi element of the present invention. In other embodiments, the frequency of one- or two-copy T-DNA transformation events is about 50%, 40%, 20%, 15%, or 10% higher than the frequency of one- or two-copy T-DNA transformation events relative to the same variety of plant transformed with plant transformation vector that does not contain the repABC element such as oriRi element of the present invention.
- Thus, certain embodiments of the present invention provide methods involving use of repABC element such as oriRi from Agrobacterium rhizogenes and repABC origin from plasmid p42b of Rhizobium etli, including the sequences set forth herein, to reduce the frequency of plants transformed with non-T-DNA vector region. The present invention is also directed to the use of repABC element such as oriRi from Agrobacterium rhizogenes and repABC origin from plasmid p42b of Rhizobium etli, including the sequences set forth herein, to increase the frequency of one- or two-copy T-DNA transformation events. In some embodiments, both methods are employed in combination to achieve transformation events having lower frequencies of backbone incorporation and higher frequencies of one- or two- copy T-DNA transformation events.
- The following examples are provided to better elucidate the practice of the present invention and should not be interpreted in any way to limit the scope of the present invention. Those skilled in the art will recognize that various modifications, additions, substitutions, truncations, etc., can be made to the methods and genes described herein while not departing from the spirit and scope of the present invention.
- Cloning steps followed standard protocols described by Sambrook et al. (1989). The 5.6 kb oriRi fragment, excised from pCGN1589 with Dral digestion, was used to replace the oriV fragment of pMON67438 that was digested with PshAI and BstXI and blunted with T4 DNA polymerase. This resulted in an oriRi base vector pMON83856 (
FIG. 1 ). The 5.6 kb oriRi testing vector pMON83882 (FIG. 2 ) was made by insertion of the gus and CP4 fragments from the oriV control vector pMON67438, sequentially digested with Accl (blunted)/BamHI, into pMON83856 that had been opened with Pmel/BamHI. To truncate the oriRi fragment, two primers, 5′CACGTGTACAAGGTAGAATCCGCCTGAG 3′ (oriRi 5′ promoter upstream; SEQ ID NO:5) and 5′GTATACAGGCTCTCCTTCACGATCAAC 3′ (oriRi 3′ after repC: SEQ ID NO:6), were synthesized and PCR was performed with high fidelity pfu polymerase and pMON83856 as a template. The PCR product was purified and inserted into pMON83930, which was digested with Afel and Xhol and blunted with T4 DNA polymerase, to replace oriV fragment. The resulting vector pMON83934 (FIG. 3 ), with the truncated oriRi, was then confirmed by DNA sequencing. In order to make the testing vector pMON83937 (FIG. 4 ) with a truncated oriRi, pMON83934 was opened with KpnI, blunted with T4 DNA polymerase, and followed by BamHI digestion; the gus and Cp4 fragment from oriV control vector pMON67438 was sequentially digested with AccI, filled in with T4 DNA polymerase, and then further digested with BamHI. The two fragments were ligated with T4 DNA ligase and resulted in pMON83937. - To construct the corn transformation vector pMON97352 (
FIG. 5 ), a linker sequence containing Spel and PspOMI sites were synthesized by annealing twooligos 5′-AGCTTGGGCCCCTCGAGGCTAGCACTAGTG-3′ (SEQ ID NO:7 and 5′-GATCCACTAGTGCTAGCCTCGAGGGGCCCA-3′ (SEQ ID NO: 8), and inserted into pMON83856 with the BamHI and HindIII digestion. The resulting intermediate oriRi vector was opened with Spel and PspOMI and ligated with the CP4 and gus expression cassettes excised from pMON92726 (FIG. 6 ) with Notl and SpeI digestion (seeFIG. 5 , pMON97352). The oriV parental vector pMON992726 was used as a control vector to compare with corn oriRi test vector pMON97352. - To construct oriV 2T control vector pMON87488 (
FIG. 7 ), the octopine right border was excised from pMON51676, blunted with T4 DNA polymerase and inserted into pMON87485 which was opened with SalI/SpeI, filled-in with T4 DNA polymerase and CIP treated. To make the oriRi 2T vectors, pMON96001 (FIG. 8 ) and pMON96010 (FIG. 9 ), the oriV in pMON87488 was removed with Afel and Xhol, the vector was filled-in with T4 DNA polymerase and inserted with the 4.2 kb oriRi replicon from pMON83934 obtained by digesting pMON83934 with Pm1I and BstZ17I, resulting into pMON96001. The 5.6 kb oriRi replicon from pCGN1589 obtained by digesting it with Dral digestion was inserted to yield pMON96010. - Transformation of soybean cells and regeneration of the cells into intact fertile plants by Agrobacterium-mediated transformation can be conducted using various methods known in the art. A method for soybean transformation (e.g. U.S. Pat. Nos. 6,384,301 and 7,002,058) was utilized with an organogenesis process.
- The DNA constructs described in the present invention (e.g., plasmid pMON83882, substantially as shown in
FIG. 2 , and plasmid pMON83937, substantially as shown inFIG. 4 ) are transformed into a disarmed Agrobacterium strain ABI. The two oriV control vectors, pMON67438 and pMON83898 (same GOI but in different orientations), were also transferred into Agrobacterium cells. Two T DNA constructs and respective controls as described above were also used for transforming soybean. The DNA construct was transferred into Agrobacterium by electroporation. Single colonies were recovered on LB medium withspectinomycin 50 mg/1 (for oriRi vectors) or 75 mg/1 (for oriV vectors) andkanamycin 50 mg/l and inoculated in 20-50 ml liquid LB medium with same selection in a shaker with 200 rpm. The plasmid in the Agrobacterium was verified by restriction enzyme digestion of mini-prepared plasmid from 10 ml culture. The remainder of the liquid culture was mixed with glycerol to a final concentration of 20%, aliquoted and stored at -80 C as seed cultures. - To prepare the Agrobacterium inoculum for transformation, 0.25-1 ml frozen seed culture was inoculated into 250 or 500 ml LB medium with same antibiotic selection as above-mentioned and grown overnight at 26° C-28° C. with shaking at 200 rpm to mid-log growth phase. The culture was spun down and directly suspended in an inoculation medium (INO medium) at the concentration of OD660 about 0.3, as measured on a spectrophotometer.
- Soybean cultivar A3525 was used for Agrobacterium-mediated transformation as described (e.g. U.S. Pat. No. 7,002,058). Soybean seeds were germinated for less than 14 hours at room temperature in BGM medium and the meristem explants from soy mature seeds were excised by machine as described in the U.S. Patent Application 20050005321. For batch sonication, about 100 explants in PLANTCON lid were mixed with 20 ml of the Agrobacterium suspension in INO medium and sonicated in W-113 Sonicator for 20 seconds. For bulk sonication, about 1000 explants in plantcon lid were mixed with 100 ml of the Agrobacterium suspension in INO medium and sonicated for 20 seconds. After sonication, the explants were co-cultured in the same PLANTCON for 2-4 days at 23° C. with 16/8 hour light/dark period. Then the explants were transferred onto the surface of the WPM selection medium with 75 μM glyphosate. Each PLANTCON contained about 50 explants. After 2 weeks, explants were transferred again to 75 uM glyphosate solid WPM medium with primary radicle inserted in medium, each PLANTCON containing about 25 explants. Shoots with fully expanded trifolia recovered after 6-10 weeks post-inoculation were rooted in BRM medium with IAA 0.1 mg/l and 25 μM glyphosate selection. The rooted plantlets were transferred to greenhouse for maturity. Various media used for soybean transformation is detailed below in Table 1.
- The above transformation and regeneration methods provides for plants that are greatly reduced in the occurrence of vector backbone DNA. Additionally, the plants have an added benefit of having reduced copy number of the insert T-DNA. The plants produced by the method are an aspect of the invention.
-
TABLE 1 Media components for soybean transformation amount/L Compound BGM medium for soybean seed germination 0.505 g Potassium nitrate 0.24 g Ammonium nitrate 0.493 g Magnesium sulfate 0.176 g Calcium chloride 27.2 mg Potassium phosphate monobasic 1.86 mg Boric acid 5.07 mg Manganese sulfate 2.58 mg Zinc sulphate 0.249 mg Potassium iodide 0.216 mg Sodium Molybdate 0.00025 mg Copper sulphate 0.00025 mg Cobalt chloride stock 3.36 mg Disodium EDTA 2.49 mg Ferrous sulphate 1.34 mg Thiamine HCl 0.5 mg Nicotinic acid 0.82 mg Pyridoxine HCl 20 g/L Sucrose (Ultra Pure) 1.29 g Calcium Gluconate (Sigma #G4625) 60 mg Benomyl pH 5.6 INO medium for soy co-culture 1/10 B5 medium components 1 g Potassium Nitrate (KNO3) 30 g Glucose 3.9 g MES (pH 5.4) After autoclaving, lipoic acid added to inoculum to final concentration 250 μM SOY WPM shooting medium 2.41 g WPM Powder (Phytotech Lab) Add the WPM into water with stirring on a magnetic stirrer. After dissolving, add following compounds sequentially: 20 g Sucrose (Ultra Pure) 1.29 g Calcium Gluconate (Sigma) 60 mg Benomyl (or no fungicide) 4.0 g AgarGel (pH 5.6) mL/ L Post-autoclaving ingredients 4 mL Cefotaxime (50 mg/mL) 1 ml Ticarcillin (100 mg/ml) 5 mL Carbenicillin (40 mg/mL) 0.15 mL Glyphosate (0.5 FS Stock) (0.075 mM) BRM rooting medium amount/L Compound 2.15 g MS Powder (Gibco/Invitrogen) 0.1 g myo - Inositol 2 mg Glycine 0.5 mg Nicotinic acid 0.5 mg Pyrodoxine HCl 0.5 mg Thiamine HCl 30 g Sucrose (Ultra Pure) 10 ml L-Cysteine (10 mg/ml) 8 g Washed Agar mL/L Post-autoclaving ingredients 5.0 IAA (0.033 mg/ml in 1 mM KOH) 1 mL Ticarcillin (100 mg/ml) 0.05 mL Glyphosate (0.5 FS Stock) (0.025 mM) 0.1 mL IAA (1.0 mg/ml) - Other dicot plant cells can be transformed and regenerated into intact plants by methods known in the art of plant transformation and tissue culture. The use of Agrobacterium-mediated methods to transfer the T-DNA of the plasmids of the present invention are well known in the art. For example cotton (U.S. Pat. Nos. 5,004,863; 5,159,135; 5,518,908, 5,846,797, and 6,624,344, herein incorporated by reference) and Brassica (U.S. Pat. No. 5,750,871).
- Two vectors, pMON97352 (oriRi, single copy in Agrobacterium) and pMON92726 (ori V, multiple copies in Agrobacterium as a control) containing same plant selectable marker gene CP4 and gus gene cassettes, both driven by rice actin promoters (
FIG. 5 ), were electroporated into Agrobacterium tumefaciens strain ABI for corn transformation. Agrobacterium containing the vector in glycerol stock was streaked out on solid LB medium supplemented with antibiotics (all in active ingredient) kanamycin (40 mg/L), spectinomycin (31 mg/L), streptomycin (38 mg/L) and chloramphenicol (25 mg/L) and incubated at 28° C. for 2 days. Two days before Agrobacterium inoculation of the maize immature embryos, one colony or a small loop of Agrobacterium from the Agrobacterium plate was picked up and inoculated into 25 mL of liquid LB medium supplemented with 62 mg/L of spectinomycin and 40 mg/L of kanamycin in a 250 mL flask. The flask was placed on a shaker at approximately 150-200 rpm and 27-28° C. overnight. The Agrobacterium culture was then diluted (1 to 5) in the same liquid medium and put back on the shaker. Several hours later, one day before inoculation, the Agrobacterium cells were spun down at 3500 rpm for 15 min. The bacterium cell pellet was re-suspended in induction broth with 200 μM of acetosyringone and 50 mg/L spectinomycin and 25 mg/L kanamycin and the cell density was adjusted to 0.2 at OD660. The bacterium cell culture (50 mL in each 250 mL flask) was then put back on the shaker and grown overnight. On the morning of inoculation day, the bacterium cells were spun down and washed with liquid ½ MS VI medium (Table 2) supplemented with 200 μM of acetosyringone. After one more centrifugation, the bacterium cell pellet is re-suspended in ½ MS PL medium (Table 2) with 200 μM of acetosyringone (Table 2) and the cell density was adjusted to 1.0 at OD660 for inoculation. - Reagents are commercially available and can be purchased from a number of suppliers (see, for example Sigma Chemical Co., St. Louis, Mo.).
-
TABLE 2 Media used in Example 3 Co-culture Component ½ MSVI ½ MSPL medium Induction MS MSW50 MS/6BA MSOD MS salts 68.5 g/L 68.5 g/L 2.2 g/L 4.4 g/L 4.4 g/L 4.4 g/L 4.4 g/L Sucrose 20 g/L 68.6 g/L 20 g/L 30 g/L 30 g/L 30 g/L — Maltose — — — — — — 20 g/L Glucose 10 g/L 36 g/L 10 g/L — — — 10 g/L 1-Proline 115 mg/L 115 g/L 115 g/L 1.36 g/L 1.38 g/L 1.36 g/L — Casamino Acids — — — 50 mg/L 500 mg/L 50 mg/L — Glycine 2 mg/L 2 mg/L 2 mg/L — 2 mg/L — — 1-Asparagine — — — — — — 150 mg/L myo-Inositol 100 mg/L 100 mg/L 100 mg/L — 100 mg/L 100 mg/L 100 mg/L Nicotinic Acid 0.5 mg/L 0.5 mg/L 0.5 mg/L 1.3 mg/L 0.5 mg/L 1.3 mg/L 1.3 mg/L Pyridoxine HCl 0.5 mg/L 0.5 mg/L 0.5 mg/L 0.25 mg/L 0.5 mg/L 0.25 mg/L 0.25 mg/L Thiamine HCl 0.1 mg/L 0.1 mg/L 0.6 mg/L 0.25 mg/L 0.6 mg/L 0.25 mg/L 0.25 mg/L Ca Pantothenate — — — 0.25 mg/L — 0.25 mg/L 0.25 mg/L 2,4-D — — 3 mg/L 0.5 mg/L 0.5 mg/L — — Picloram — — — 2.2 mg/L — — — Silver Nitrate — — 1.7 mg/L 1.7 mg/L — — — BAP — — — — — 3.5 mg/L — Media ½ MSVI and ½ MSPL were used as liquid. Co-culture medium was solidified with 5.5 mg/L low EEO agarose. All other media were solidified with 3 g/L phytagel for glyphosate selection. - Corn line LH244 (U.S. Pat. No. 6,252,148) was used in this study. Ears containing immature embryos were harvested and kept refrigerated at 4° C. until use. Immature embryos were isolated from surface sterilized ears and directly dropped into the prepared
- Agrobacterium cell suspension in microcentrifuge tube and inoculated for 5 to 20 min. After Agrobacterium cell suspension was removed using a fine tipped sterile transfer pipette, the immature embryos were transferred onto the co-culture medium (Table 2). The embryos were cultured in a dark incubator (23° C.) for approximately 24 h.
- After the co-cultivation, the embryos were transferred onto a modified MS medium (Induction MS, Table 2) supplemented with 500 mg/L carbenicillin and 0.1mM glyphosate at 30° C. for 2 weeks followed by an additional week in a dark culture room at 27-28° C. All the callus pieces were then transferred individually onto the first regeneration medium, the same medium mentioned above except 2,4-D and picloram were replaced by 3.5 mg/L BAP (MS/6BA, Table 2) and the carbenicillin level was dropped to 250 mg/L. The cultures were moved to a culture room with 16-h light/8-h dark photoperiod and 27° C. After 5-7 days, the callus pieces were transferred onto the second regeneration medium (MSOD, Table 2). In another 2 weeks, the callus pieces that had shoots regenerated were transferred onto the same hormone-free medium in PhytatraysTM for further growth. Regenerated plants (RO) with one or more healthy roots were moved to soil in peat pots in a growth chamber. In 7 to 10 days, they were transplanted into 12-inch pots and moved to a greenhouse with conditions for normal corn plant growth. The plants were either self-pollinated or crossed with wild-type plants.
- DNA was extracted from tissue samples collected from greenhouse grown plants transformed with the DNA plasmids of the present invention. A PCR-based method was used to assay the DNA for the presence of the oriRi sequence using repA forward primer 5ACAAGGTAGAATCCGCCTGAG-3′ (Xd487b; SEQ ID NO:11) and repA reverse primer 5-TTCAACTCTGGCATCTCAGAC-3′ (Xd488; SEQ ID NO:12) as an indicator of vector backbone. This DNA is adjacent to the LB and its presence in the DNA extracted from the regenerated plants indicates that transfer of vector sequences beyond the LB has occurred. DNA can be isolated from plant tissues by any number of methods for example, the CTAB procedure (Rogers et al., 1985) or
DNAeasyTM 96 Plant Kit (Cat. # 69181, Qiagen Inc., Valencia, Calif.) following the manufacturers instructions. Taqman® (PE Applied Biosystems, Foster City, Calif.) is described as a method of detecting and quantifying the presence of a DNA sequence and is fully understood in the instructions provided by the manufacturer. DNA primer molecules (SEQ ID NO:11 and 12) were used in the described method to identify the oriRi DNA from plant extracts. The conditions and apparatus used can be modified by those skilled in the art to provide the same results. - Soybean meristem axis excised from mature seeds were transformed with a control DNA plasmid (pMON67438 or pMON83898) and a plasmid of the present invention (pMON83882 or pMON83937), then regenerated into intact plants. The intact plants were analyzed for the presence of the gene of interest (CP4) and non T-DNA oriRi and oriV sequences. Table 3 shows the results of this analysis.
- Out of 39 plants tested, only 3 had vector backbone sequences, a frequency of 7.7%. In comparison, the control plasmid (an oriV plasmid) exhibited a vector backbone frequency of from 21% to 25% (depending on which samples were considered). This difference was quite dramatic and entirely unexpected.
- Another important component of a commercially viable transgenic plant is the occurrence of low insert complexity. This is often referred to as “low copy number.” It is difficult to select progeny and to successfully breed the transgenic trait if the copy number of the insert is too high. Ideally, only a single copy of the transgene would be present in a transgenic event.
- Copy number can be determined by several methods known in the art of molecular biology. Southern blot analysis is the most commonly used method. Methods using the Invader® technology (Third Wave Inc. Madison, Wis.) are also used for determining copy number of T-DNA inserts in transgenic plants.
- The soybean plant cells were transformed with a control DNA plasmid (pMON67438) and a plasmid of the present invention (pMON83882), then regenerated into intact plants, as described above. The resulting transgenic plants were analyzed for copy number using two different methods: 1) “Invader CP4” method and 2) Southern blotting. The results are shown in Table 3.
-
TABLE 3 pRi ori vector backbone effects on transformation frequency, copy number, and the insert in soybean transformation. Invader CP4 Invader CP4 Southern pMON TFa Backbone 1 Copy 1 + 2 Copy GUS Copy # 83882 1.26% 7.7% (3/39) 41% (16/39) 79.5% (31/39) 56.4% (22/39) (5.6 kb oriRi 1 Copy oriRi) 33.3% (13/39) 2 Copy 67438 1.4% 21% (8/38)b 37% (14/38) 60% (23/38) N/A (oriV) 25% (56/226)c 25% (57/226) 63% (142/226) N/A oriV aPooled data from three side by side experiments. bPlant number from side by side comparison. cPooled plant number of pMON67438 plants produced. - Using the “Invader CP4” method, the inventive plasmid, pMON83882, resulted in single-copy transformation events 41% of the time, as compared to the control plasmid pMON67438 which resulted in a single-copy transformation event only 25% of the time using pooled samples of other experiments or only 37% of the time using side by side experiments. Considering one- and two-copy events together, pMON83882 resulted in said events 79.5% of the time, as compared to 60% from side by side experiments and 63% from pooled samples employing the control plasmid. Using the Southern blotting comparison, pMON83882 produced one-copy events 56.4% of the time and 33.3% of the time two-copy events, for a total of nearly 90% one- and two-copy events combined. Again, these results were both dramatic and unexpected.
- In order to analyze the oriRi impact on 2T-DNA transformation, the 4.2 kb oriRi 2T vector pMON96001 was side by side compared with the oriV 2T vector pMON87488 for six times. The 5.6 kb oriRi 2T vector pMON96010 was also included in the last two comparison experiments in these preliminary experiments (Table 4, Group A). Total DNA was extracted from seed segments of mature seeds harvested from greenhouse and used to determine transgene copy number by Invader technology using CP4 probe and NOS probes.
CP 4 Invader® detection assay used the following sequence as a targeting site: 5′TCGCTTTCCTTGACGCGGAGTTCTTCCA GACCGTTCAT CACGG 3′ (SEQ ID NO: 13) and GTAGGTGATTGGCGTTG (SEQ ID NO:14) as a probe sequence. NOS Invader® detection assay used the followingnos 3′ sequence as a targeting site TGAATTACGTTAAGCATGTAATAATTAACATGTAATGCATGACT (SEQ ID NO:15 and GTTATTTATGAGATGGGTTTTTATGA (SEQ ID NO:16) as NOS Invader® probe sequence. - The 1 and/or 2 copy transformants were increased from 35% in the control oriV vector to over 40% in both oriRi vectors. The frequency of marker-free plants in RO plants (marker free events/total RO plants) was increased from 4.76% in the oriV control vector to 16.4% and 18.4%, respectively, in the two oriRi vector. Overall, the marker-free transformation frequency (marker free events/initial explant number) more than doubled in the two oriRi 2T vectors compared to the oriV 2T vector.
- Additional in-parallel experiments with larger initial explant number were further used to compare the oriV control 2T vector with the 4.2 kb oriRi 2T vector (Table 4, Group B). The oriRi 2T vector reproduced the results: the 1+2 copy event frequency and the marker free frequency (MF%) are both increased and the marker-free transformation frequency is more than doubled in the oriRi vector. The results indicated that the oriRi 2T vectors are significantly more efficient to produce marker free plants than the oriV 2T vector by increasing low copy events and improving marker free transformation frequency.
-
TABLE 4 Effect of type of origin of replication on 2T-DNA vector transformation of soybean. Explant R0 TF 1 1 + 2 copy 2 MF Events 3 MF % 4 Construct Total plant # (%) Co-T (analyzed) plants MF TF 5 Group A pMON87488 4318 84 1.95 32.9% (25/76) 4 (25) 4.76% (4/84) 0.09% (oriV) pMON96001 (4.2 4757 67 1.41 42.4% (25/59) 11 (24) 16.41% (11/67) 0.23% kb oriRi) pMON96010 (5.6 1575 38 2.41 41.7% (15/36) 7 (15) 18.42% (7/38) 0.44% kb oriRi) Group B pMON87488 11024 145 1.31 35.7% (30/84) 9 (30) 6.2% (9/145) 0.08% (oriV) pMON96001 (4.2 8660 107 1.24 43.8%% (39/89) 16 (38) 14.95% (16/107) 0.18% kb oriRi) Note: 1TF: transformation frequency = R0 plants/total explants; 2 1 + 2 copy Co-T: 1 and/or 2 copy gus and CP4 marker 2 T-DNA co-transformants. Only 1-2 copy events were further advanced to analyze the marker segregation in seeds; 3 MF events: gus gene positive, marker-free events from the 1 + 2 copy co-transformants analyzed by seed segregation; 4 MF % plants: gus positive, marker free plants/R0 plant #; 5 Marker-free transformation frequency (MF TF) = unlinked event #/initial explant #. - To investigate the oriRi replication origin effect on corn transformation, the 5.6 kb oriRi vector pMON97352 containing gus and CP4 genes, both driven by rice actin promoter, was compared to the oriV vector pMON92726 with the same T-DNA structure containing gus and CP4 genes. Corn immature embryos from Cultivar LH244 were inoculated with Agrobacterium containing either the oriRi or the oriV vector in parallel. Each treatment consisted of about 110 embryos. In total 16 side by side comparison experiments were initiated. The oriRi vector showed significantly lower transformation frequency than the oriV control vector (
FIG. 10 ) with average TF 9.5% and 16.3% for oriRi and oriV vectors, respectively. However, the overall transformation efficiency with oriRi and oriV vectors was same. - The presence of backbone sequence in transgenic corn plants was determined by Endpoint TaqMan® assay (Applied Biosystems, Foster City, Calif).for the oriRi or oriV sequence, LB sequences that are 3′ flanking for short read-through close to the LB nicking site and RB sequences that are 5′ flanking before the RB nicking site for intact backbone readthrough. The
oriV primers 5′AACGCCTGATTTTACGCGAG 3′ (forward; SEQ ID NO: 17) and 5′CAATACCGCAGGGCACTTATC 3′ (reverse; SEQ ID NO:18), with probe CCCACAGATGATGTGGAC (SEQ ID NO:19) labeled with fluorescent dye 6-FAM at the 5′ end. The oriRi primers are 5′TGGCAAGGAATGGGTTTGAG 3′ (forward; SEQ ID NO:20) and 5′CTACAACTACAGGCGCTGCTTTT 3′ (reverse; SEQ ID NO:21) with the probe 6-FAM-TGGCGAAGTCTGTCC (SEQ ID NO:22) to detect oriRi sequence 621 bp downstream of LB nicking site. TheRB 5′ flanking primers are 5′GCCAAGGGATCTTTTTGGAAT 3′ (forward; SEQ ID NO:23) and 5′CCACCCAAACGTCGGAAA 3′ (reverse; SEQ ID NO:24) with the probe 6FAM-TGCTCCGTCGTCAGG (SEQ ID NO:25) to detect 5′ RB flanking 186 bp before the RB nicking site. The primers for detecting LB 35 bp downstream of the LB nicking site were 5′GCACCCGGTGGAGCTT 3′ (forward; SEQ ID NO:26) and 5′TCTGCCTAACCGGCTCAGT 3′ (reverse; SEQ ID NO:27) with the probe CATGTTGGTTTCTACGCAG (SEQ ID NO:28) labeled with fluorescent dye 6-FAM at the 5′ end. Approximately 10 ng DNA was used for Endpoint TaqMan® reaction according to the manufacturer's instruction (Applied Biosystems, Foster City, Calif.). - As shown in
FIG. 11 , about 95% of the transgenic plants derived from oriRi vector were backbone-free, which is significantly better than oriV vector control showing about 78% backbone free frequency. Since the vector backbone starts at LB after nicking site and ends before RB nicking site, use of three different backbone probes (LB downstream, oriRi/oriV and RB upstream) in both oriRi and oriV vector derived plants revealed that most vector backbone transferred contained entire vector backbone sequence. - The CP4 transgene copy number was determined by Invader® assay according to the manufacturer's instruction (Third Wave Technologies Inc. Madison, Wis.) using the a CP4 sequence. The gus transgene copy number was measured by determining the gus cassette transcriptional terminator pinII (shown as
Pis 4 inFIGS. 5 and 6 ) using TaqMan® technology (Applied Biosystems, Foster City, Calif.). The pinII TaqMan® primers were 5′ATGAAATAAAAGGATGCACACAT 3′ (forward; SEQ ID NO:29) and 5′ACAACTTTGATGCCCACATT 3′ (reverse; SEQ ID NO:30) with the probe TGACATGCTAATCAC- (SEQ ID NO:31) labeled with fluorescent dyes 6-FAM at the 5′ end and MGBNFQ at the 3′ end. -
FIG. 12 shows the transgene copy number assay results. The oriRi vector significantly increased single copy plant frequency compared to the control oriV vector, while the frequency of 2 or more copy events in oriRi vector was decreased. Both TaqMan® and Invader® assays with two different probes showed similar results. Since the single copy backbone free plants are the most valuable for both research and development, the oriRi vector increasing the single copy frequency and decreasing backing containing events in corn represents a significant improvement for quality in transgenic event production. - To clone repABC replication origin from Rhizobium etli CFN42 strain, the USDA strain was obtained from USDA Rhizobium Collection Center. A 4.3 kb repABC fragment was amplified from R. etli plasmid p42b found in strain CFN42 by PCR with
primers 5′CCACGTGAGTTACGGCTGATCGACCAGAC 3′ (Xd745; SEQ ID NO:9) and 5′GCCTAGGACGTCAACTCCAACCGCACCGT 3′ (Xd746; SEQ ID NO:10) and ligated to TOPO blunt cloning vector (Invitrogen, Carlsbad, Calif., USA), which resulted in pMON96941 and was confirmed by sequencing. The repABC fragment was digested with Pm11 and AvrII (shown by underlined sequence in primers) and ligated to pMON96948 opened with Smal and AvrII. The ligate was directly transferred into Agrobacterium tumefaciens AB2 (a kanamycin sensitive strain) competent cells, and plated onto LB plate withkanamycin 50 mg/l. The kan resistant colonies were inoculated into liquid LB medium with 50 mg/l kanamycin, and a plasmid DNA was prepared by miniprep. The construct was confirmed by restriction digestion. Since the vector pMON96951 does not contains an E. coli replication origin, it can not be maintained in E. coli. - pMON96951 (
FIG. 13 ) is used for transforming plant species as described above. The transgenic events are analyzed for reduced vector backbone integration and high frequency of low-copy transformation events by methods described in Example 4. - Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
- The following are herein incorporated by reference:
- U.S. Pat. Nos. 4,581,847; 4,761,373; 4,810,648; 5,004,863; 5,013,659; 5,034,322; 5,094,945; 5,141,870; 5,159,135; 5,229,114; 5,273, 894; 5,276,268; 5,304,730; 5,378,824; 5,463,175; 5,463,175; 5,512,466; 5,516,671; 5,518,908; 5,543,576; 5,561,236; 5,591,616; 5,597,717; 5,605,011; 5,608,149; 5,627,061; 5,633,435; 5,633,437; 5,633,444; 5,637,489; 5,646,024; 5,689,041; 5,716,837; 5,719,046; 5,750,871; 5,750,876; 5,767,366; 5,773,696; 5,824,877; 5,846,797; 5,939,602; 5,942,664; 5,958,745; 5,985,605; 5,998,700; 6,011,199; 6,013,864; 6,040,497; 6,063,597; 6,063,756; 6,072,103; 6,080,560; 6,093,695; 6,110,464; 6,121,436; 6,166,292; 6,171,640; 6,225,105; 6,228,992; 6,252,148; 6,268,549; 6,316,407; 6,380,466; 6,384,301; 6,414,222; 6,444,876; 6,476,295; 6,506,962; 6,531,648; 6,537,750; 6,613,963; 6,624,344; 7,002,058; U.S. Patent Pub. 2003/0028917; U.S. Patent Pub. 20040177399; U.S. Patent Pub. U.S. Patent Pub. 20030083480; U.S. Patent Pub. 20030115626; U.S. Patent Pub. 20050005321; U.S. Patent Pub. 20030135879; U.S. Prov. Appln. 60/800,872; PCT Appln. WO04074443; PCT Appln. WO04009761; PCT Appln. WO9927116; PCT Appln. WO8704181A1; PCT Appln. WO8900193A; PCT Appln. WO8911789; PCT Appln. WO 9638567; PCT Appln. WO05107437; PCT Appln. WO05003362
- Ammirato et al., In: Handbook of Plant Cell Culture--Crop Species, Macmillan Publ. Co., 1984.
- Binns and Howitz, In: Bacterial Pathogenesis of plants and Animals, Dang (Ed.), Berlin: Stringer Verlag, 119-138, 1994.
- Fraley et al., Bio/Technology, 3:629-635, 1985.
- Hayashimoto, Plant Physiol., 93:857-863, 1990.
- Herman et al., J. Biol. Chem., 280(26):24759-24767, 2005.
Hooykaas and Beijersbergen, Ann. Rev. Phytopathol., 32:157-179, 1994. - Jefferson et al., Biochem. Soc. Trans., 15:7-19, 1987.
Kado, Crit. Rev. Plant Sci., 10:1-32, 1991.
Kanehisa, Nucl. Acids Res., 12:203-213, 1984.
Klee et al., Ann. Rev. Plant Phys., 38:467-486, 1987. - Pearson and Lipman, Proc. Natl. Acad. Sci. USA, 85(8):2444-2448, 1988.
Ream; Ann. Rev. Phytopathol., 27: 583-618, 1989. - Rogers et al., Plant Mol. Biol., 5:69-76, 1985.
Sambrook et al., In: Molecular cloning: a laboratory manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
Sambrook et al., In: Molecular cloning: a laboratory manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 9.52-9.55, 1989.
Sambrook et al., In: Molecular cloning: a laboratory manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 9.47-9.52, 9.56-9.58, 1989. - Wetmur and Davidson, J. Mol. Biol., 31:349-370, 1968.
- Wising et al. Ann. Rev. Genetics, 22, 421, 1988.
Zambryski, Ann. Rev. Plant Physiol. Plant Mol. Biol., 43: 465-490, 1992.
Zupan and Zambryski, Ann. Rev. Phytopathol., 27:583-618, 1995.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/931,315 US20210010011A1 (en) | 2005-09-06 | 2020-07-16 | Vectors and methods for improved plant transformation efficiency |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71450105P | 2005-09-06 | 2005-09-06 | |
US11/516,036 US8993846B2 (en) | 2005-09-06 | 2006-09-05 | Vectors and methods for improved plant transformation efficiency |
US14/642,674 US10202611B2 (en) | 2005-09-06 | 2015-03-09 | Vectors and methods for improved plant transformation efficiency |
US16/242,887 US10752908B2 (en) | 2005-09-06 | 2019-01-08 | Vectors and methods for improved plant transformation efficiency |
US16/931,315 US20210010011A1 (en) | 2005-09-06 | 2020-07-16 | Vectors and methods for improved plant transformation efficiency |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/242,887 Division US10752908B2 (en) | 2005-09-06 | 2019-01-08 | Vectors and methods for improved plant transformation efficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210010011A1 true US20210010011A1 (en) | 2021-01-14 |
Family
ID=37415562
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/516,036 Active 2029-03-30 US8993846B2 (en) | 2005-09-06 | 2006-09-05 | Vectors and methods for improved plant transformation efficiency |
US14/642,674 Active 2028-12-20 US10202611B2 (en) | 2005-09-06 | 2015-03-09 | Vectors and methods for improved plant transformation efficiency |
US16/242,887 Active US10752908B2 (en) | 2005-09-06 | 2019-01-08 | Vectors and methods for improved plant transformation efficiency |
US16/931,315 Abandoned US20210010011A1 (en) | 2005-09-06 | 2020-07-16 | Vectors and methods for improved plant transformation efficiency |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/516,036 Active 2029-03-30 US8993846B2 (en) | 2005-09-06 | 2006-09-05 | Vectors and methods for improved plant transformation efficiency |
US14/642,674 Active 2028-12-20 US10202611B2 (en) | 2005-09-06 | 2015-03-09 | Vectors and methods for improved plant transformation efficiency |
US16/242,887 Active US10752908B2 (en) | 2005-09-06 | 2019-01-08 | Vectors and methods for improved plant transformation efficiency |
Country Status (10)
Country | Link |
---|---|
US (4) | US8993846B2 (en) |
EP (2) | EP1941046A2 (en) |
JP (4) | JP5889508B2 (en) |
CN (1) | CN101305097A (en) |
AU (1) | AU2006287650A1 (en) |
BR (1) | BRPI0615680A2 (en) |
CA (2) | CA2621394C (en) |
MX (1) | MX2008003190A (en) |
WO (1) | WO2007030432A2 (en) |
ZA (1) | ZA200802009B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8993846B2 (en) * | 2005-09-06 | 2015-03-31 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
WO2008085605A2 (en) * | 2006-11-15 | 2008-07-17 | Purdue Research Foundation | Backbone-free low transgene copy transgenic plants |
EP2450448B1 (en) | 2007-03-09 | 2014-09-17 | Monsanto Technology LLC | Methods for plant transformation using spectinomycin selection |
EP3023499A1 (en) | 2008-07-16 | 2016-05-25 | Monsanto Technology LLC | Methods and vectors for producing transgenic plants |
JP5762400B2 (en) * | 2009-03-30 | 2015-08-12 | モンサント テクノロジー エルエルシー | Rice genetic recombination event 17053 and methods of use thereof |
CN102747096B (en) * | 2011-04-18 | 2015-04-08 | 中国医学科学院基础医学研究所 | Gene search vector, random gene mutation control method and application thereof |
US9392758B2 (en) | 2011-08-26 | 2016-07-19 | Integrated Plant Genetics, Inc. | Transformation of mature citrus |
AU2015231804B2 (en) * | 2014-03-20 | 2021-02-25 | Monsanto Technology Llc | Transgenic maize event MON 87419 and methods of use thereof |
WO2017040343A1 (en) | 2015-08-28 | 2017-03-09 | Pioneer Hi-Bred International, Inc. | Ochrobactrum-mediated transformation of plants |
US11377662B2 (en) | 2018-01-10 | 2022-07-05 | Wisconsin Alumni Research Foundation | Agrobacterium-mediated and particle bombardment transformation method for cowpea and dry bean meristem explants |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326527B1 (en) * | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US20030110532A1 (en) * | 2001-07-06 | 2003-06-12 | Toni Armostrong | Methods for enhancing segregation of transgenes in plants and compositions thereof |
US6696621B2 (en) * | 2001-02-23 | 2004-02-24 | Paradigm Genetics, Inc. | Selectable marker in plants |
US8993846B2 (en) * | 2005-09-06 | 2015-03-31 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273A (en) | 1847-09-04 | George w | ||
US5637A (en) | 1848-06-20 | Improvement in water-wheels | ||
US489A (en) | 1837-11-25 | Improvement in the mode of constructing springs for carriages, wagons | ||
US894A (en) | 1838-08-25 | Machinery for raising heavy bodies | ||
US5094945A (en) | 1983-01-05 | 1992-03-10 | Calgene, Inc. | Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use |
US5034322A (en) | 1983-01-17 | 1991-07-23 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
US4581847A (en) | 1984-09-04 | 1986-04-15 | Molecular Genetics Research And Development | Tryptophan overproducer mutants of cereal crops |
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
BR8705281A (en) | 1986-01-08 | 1987-12-22 | Rhone Poulenc Agrochimie | HALOARYLNITRILLA DEGRADING GENE, ITS USE, AND CELLS CONTAINING THE SAME |
ES2018274T5 (en) | 1986-03-11 | 1996-12-16 | Plant Genetic Systems Nv | VEGETABLE CELLS RESISTANT TO GLUTAMINE SYNTHETASE INHIBITORS, PREPARED BY GENETIC ENGINEERING. |
US5750871A (en) | 1986-05-29 | 1998-05-12 | Calgene, Inc. | Transformation and foreign gene expression in Brassica species |
US5276268A (en) | 1986-08-23 | 1994-01-04 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
US5273894A (en) | 1986-08-23 | 1993-12-28 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
US5637489A (en) | 1986-08-23 | 1997-06-10 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
US5378824A (en) | 1986-08-26 | 1995-01-03 | E. I. Du Pont De Nemours And Company | Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
US5013659A (en) | 1987-07-27 | 1991-05-07 | E. I. Du Pont De Nemours And Company | Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
US5605011A (en) | 1986-08-26 | 1997-02-25 | E. I. Du Pont De Nemours And Company | Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
CN87100603A (en) | 1987-01-21 | 1988-08-10 | 昂科公司 | Vaccines against melanoma |
US5229114A (en) | 1987-08-20 | 1993-07-20 | The United States Of America As Represented By The Secretary Of Agriculture | Approaches useful for the control of root nodulation of leguminous plants |
US5244802A (en) | 1987-11-18 | 1993-09-14 | Phytogen | Regeneration of cotton |
US5258300A (en) | 1988-06-09 | 1993-11-02 | Molecular Genetics Research And Development Limited Partnership | Method of inducing lysine overproduction in plants |
US5416011A (en) | 1988-07-22 | 1995-05-16 | Monsanto Company | Method for soybean transformation and regeneration |
GB8825402D0 (en) | 1988-10-31 | 1988-11-30 | Cambridge Advanced Tech | Sulfonamide resistance genes |
US5689041A (en) | 1989-08-10 | 1997-11-18 | Plant Gentic Systems N.V. | Plants modified with barstar for fertility restoration |
US6117677A (en) * | 1990-03-16 | 2000-09-12 | Thompson; Gregory A. | Plant stearoyl-ACP desaturases genes |
US5543576A (en) | 1990-03-23 | 1996-08-06 | Mogen International | Production of enzymes in seeds and their use |
US5498830A (en) | 1990-06-18 | 1996-03-12 | Monsanto Company | Decreased oil content in plant seeds |
WO1992000377A1 (en) | 1990-06-25 | 1992-01-09 | Monsanto Company | Glyphosate tolerant plants |
US5633435A (en) | 1990-08-31 | 1997-05-27 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
WO1992012249A1 (en) | 1990-12-26 | 1992-07-23 | Monsanto Company | Control of fruit ripening and senescence in plants |
US5767366A (en) | 1991-02-19 | 1998-06-16 | Louisiana State University Board Of Supervisors, A Governing Body Of Louisiana State University Agricultural And Mechanical College | Mutant acetolactate synthase gene from Ararbidopsis thaliana for conferring imidazolinone resistance to crop plants |
US5304730A (en) | 1991-09-03 | 1994-04-19 | Monsanto Company | Virus resistant plants and method therefore |
US5518908A (en) | 1991-09-23 | 1996-05-21 | Monsanto Company | Method of controlling insects |
ATE398679T1 (en) | 1992-07-07 | 2008-07-15 | Japan Tobacco Inc | METHOD FOR TRANSFORMING A MONOCOTYLEDON PLANT |
US6011199A (en) | 1992-12-15 | 2000-01-04 | Commonwealth Scientific | Method for producing fruiting plants with improved fruit flavour |
US6013864A (en) | 1993-02-03 | 2000-01-11 | Monsanto Company | Plants resistant to infection by luteoviruses |
US6414222B1 (en) | 1993-02-05 | 2002-07-02 | Regents Of The University Of Minnesota | Gene combinations for herbicide tolerance in corn |
JP3759628B2 (en) | 1993-06-08 | 2006-03-29 | 麒麟麦酒株式会社 | Production of bleaching herbicide-tolerant plants |
BR9408140A (en) | 1993-11-24 | 1997-08-12 | Monsanato Company | Process for controlling plant pathogens |
US5939602A (en) | 1995-06-06 | 1999-08-17 | Novartis Finance Corporation | DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof |
US6080560A (en) | 1994-07-25 | 2000-06-27 | Monsanto Company | Method for producing antibodies in plant cells |
US5750876A (en) | 1994-07-28 | 1998-05-12 | Monsanto Company | Isoamylase gene, compositions containing it, and methods of using isoamylases |
US5633437A (en) | 1994-10-11 | 1997-05-27 | Sandoz Ltd. | Gene exhibiting resistance to acetolactate synthase inhibitor herbicides |
US5716837A (en) | 1995-02-10 | 1998-02-10 | Monsanto Company | Expression of sucrose phosphorylase in plants |
FR2734842B1 (en) | 1995-06-02 | 1998-02-27 | Rhone Poulenc Agrochimie | DNA SEQUENCE OF A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE AND OBTAINING PLANTS CONTAINING A HYDROXY-PHENYL PYRUVATE DIOXYGENASE GENE, TOLERANT TO CERTAIN HERBICIDES |
US5846797A (en) | 1995-10-04 | 1998-12-08 | Calgene, Inc. | Cotton transformation |
US6946588B2 (en) | 1996-03-13 | 2005-09-20 | Monsanto Technology Llc | Nucleic acid encoding a modified threonine deaminase and methods of use |
US5958745A (en) | 1996-03-13 | 1999-09-28 | Monsanto Company | Methods of optimizing substrate pools and biosynthesis of poly-β-hydroxybutyrate-co-poly-β-hydroxyvalerate in bacteria and plants |
US5773696A (en) | 1996-03-29 | 1998-06-30 | Monsanto Company | Antifungal polypeptide and methods for controlling plant pathogenic fungi |
US6166292A (en) | 1996-04-26 | 2000-12-26 | Ajinomoto Co., Inc. | Raffinose synthetase gene, method of producing raffinose and transgenic plant |
US5985605A (en) | 1996-06-14 | 1999-11-16 | Her Majesty The Queen In Right Of Canada, As Represented By The Dept. Of Agriculture & Agri-Food Canada | DNA sequences encoding phytases of ruminal microorganisms |
US5998700A (en) | 1996-07-02 | 1999-12-07 | The Board Of Trustees Of Southern Illinois University | Plants containing a bacterial Gdha gene and methods of use thereof |
US5845797A (en) * | 1996-07-31 | 1998-12-08 | Daikyo Seiko, Ltd. | Rubber plug for drug vessel |
US6063756A (en) | 1996-09-24 | 2000-05-16 | Monsanto Company | Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
US6093695A (en) | 1996-09-26 | 2000-07-25 | Monsanto Company | Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |
US6017534A (en) | 1996-11-20 | 2000-01-25 | Ecogen, Inc. | Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity |
US5942664A (en) | 1996-11-27 | 1999-08-24 | Ecogen, Inc. | Bacillus thuringiensis Cry1C compositions toxic to lepidopteran insects and methods for making Cry1C mutants |
US6121436A (en) | 1996-12-13 | 2000-09-19 | Monsanto Company | Antifungal polypeptide and methods for controlling plant pathogenic fungi |
US6040497A (en) | 1997-04-03 | 2000-03-21 | Dekalb Genetics Corporation | Glyphosate resistant maize lines |
US6171640B1 (en) | 1997-04-04 | 2001-01-09 | Monsanto Company | High beta-conglycinin products and their use |
US7105724B2 (en) | 1997-04-04 | 2006-09-12 | Board Of Regents Of University Of Nebraska | Methods and materials for making and using transgenic dicamba-degrading organisms |
US6380466B1 (en) | 1997-05-08 | 2002-04-30 | Calgene Llc | Production of improved rapeseed exhibiting yellow-seed coat |
DK1009842T3 (en) * | 1997-06-30 | 2004-09-27 | Syngenta Mogen Bv | Plasmids for plant transformation and methods for their use |
IL122270A0 (en) | 1997-11-20 | 1998-04-05 | Yeda Res & Dev | DNA molecules conferring to plants resistance to a herbicide and plants transformed thereby |
US6072103A (en) | 1997-11-21 | 2000-06-06 | Calgene Llc | Pathogen and stress-responsive promoter for gene expression |
US6063597A (en) | 1997-12-18 | 2000-05-16 | Monsanto Company | Polypeptide compositions toxic to coleopteran insects |
US6284948B1 (en) | 1998-05-18 | 2001-09-04 | Pioneer Hi-Bred International, Inc. | Genes and methods for control of nematodes in plants |
MXPA00012100A (en) | 1998-06-05 | 2003-04-22 | Calgene Llc | Acyl coa:cholesterol acyltransferase related nucleic acid sequences. |
AU771958B2 (en) | 1998-08-04 | 2004-04-08 | Cargill Incorporated | Plant fatty acid desaturase promoters |
US6531648B1 (en) | 1998-12-17 | 2003-03-11 | Syngenta Participations Ag | Grain processing method and transgenic plants useful therein |
WO2000042207A2 (en) | 1999-01-14 | 2000-07-20 | Monsanto Technology Llc | Soybean transformation method |
EP1171620A1 (en) | 1999-05-13 | 2002-01-16 | Monsanto Technology LLC | Acquired resistance genes in plants |
US6603061B1 (en) * | 1999-07-29 | 2003-08-05 | Monsanto Company | Agrobacterium-mediated plant transformation method |
US6252148B1 (en) | 1999-12-06 | 2001-06-26 | Holden's Foundation Seeds Llc | Inbred corn line LH244 |
US6613963B1 (en) | 2000-03-10 | 2003-09-02 | Pioneer Hi-Bred International, Inc. | Herbicide tolerant Brassica juncea and method of production |
WO2002036782A2 (en) | 2000-10-30 | 2002-05-10 | Maxygen, Inc. | Novel glyphosate n-acetyltransferase (gat) genes |
US6514299B1 (en) | 2000-11-09 | 2003-02-04 | Millennium Fuels Usa, Llc | Fuel additive and method therefor |
US6746387B2 (en) | 2001-07-10 | 2004-06-08 | Kryptane Systems, Inc. | Agricultural roller |
AU2003247962B2 (en) | 2002-07-18 | 2008-06-12 | Monsanto Technology Llc | Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
CN1745173B (en) | 2002-12-18 | 2012-11-28 | 阿则耐克斯公司 | Genes conferring herbicide resistance |
CA2509227C (en) * | 2002-12-19 | 2013-05-21 | Monsanto Technology, Llc | Elevation of oil levels in brassica plants |
EP1594961B1 (en) | 2003-02-18 | 2013-12-25 | Monsanto Technology LLC | Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps) |
WO2005003362A2 (en) | 2003-03-10 | 2005-01-13 | Athenix Corporation | Methods to confer herbicide resistance |
US7575917B2 (en) | 2003-04-09 | 2009-08-18 | Monsanto Technology Llc | DNA constructs and methods to enhance the production of commercially viable transgenic plants |
US7402734B2 (en) | 2003-06-16 | 2008-07-22 | Monsanto Technology Llc | Method and apparatus for preparation of genetically transformable plant tissue |
EP2308976B2 (en) | 2004-04-30 | 2017-05-10 | Dow AgroSciences LLC | Novel herbicide resistance gene |
EP2361986A1 (en) | 2006-05-16 | 2011-08-31 | Monsanto Technology LLC | Use of non-agrobacterium bacterial species for plant transformation |
-
2006
- 2006-09-05 US US11/516,036 patent/US8993846B2/en active Active
- 2006-09-06 AU AU2006287650A patent/AU2006287650A1/en not_active Abandoned
- 2006-09-06 CN CNA2006800414265A patent/CN101305097A/en active Pending
- 2006-09-06 WO PCT/US2006/034503 patent/WO2007030432A2/en active Application Filing
- 2006-09-06 MX MX2008003190A patent/MX2008003190A/en active IP Right Grant
- 2006-09-06 BR BRPI0615680-0A patent/BRPI0615680A2/en not_active Application Discontinuation
- 2006-09-06 EP EP06802936A patent/EP1941046A2/en not_active Ceased
- 2006-09-06 CA CA2621394A patent/CA2621394C/en active Active
- 2006-09-06 CA CA2965377A patent/CA2965377C/en active Active
- 2006-09-06 JP JP2008530131A patent/JP5889508B2/en active Active
- 2006-09-06 EP EP19161091.4A patent/EP3536793A1/en active Pending
-
2008
- 2008-03-03 ZA ZA200802009A patent/ZA200802009B/en unknown
-
2014
- 2014-05-21 JP JP2014105544A patent/JP6046079B2/en active Active
-
2015
- 2015-03-09 US US14/642,674 patent/US10202611B2/en active Active
- 2015-11-30 JP JP2015233457A patent/JP6077631B2/en active Active
-
2016
- 2016-11-22 JP JP2016226968A patent/JP6348952B2/en active Active
-
2019
- 2019-01-08 US US16/242,887 patent/US10752908B2/en active Active
-
2020
- 2020-07-16 US US16/931,315 patent/US20210010011A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326527B1 (en) * | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US6696621B2 (en) * | 2001-02-23 | 2004-02-24 | Paradigm Genetics, Inc. | Selectable marker in plants |
US20030110532A1 (en) * | 2001-07-06 | 2003-06-12 | Toni Armostrong | Methods for enhancing segregation of transgenes in plants and compositions thereof |
US8993846B2 (en) * | 2005-09-06 | 2015-03-31 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
US10202611B2 (en) * | 2005-09-06 | 2019-02-12 | Monsanto Technology Llc | Vectors and methods for improved plant transformation efficiency |
Non-Patent Citations (1)
Title |
---|
Krugel et al (Analysis of the nourseothricin-resistance gene (nut) of Streptomyces noursei. Gene, 62 (1988) 209-217, 1988) (Year: 1988) * |
Also Published As
Publication number | Publication date |
---|---|
CN101305097A (en) | 2008-11-12 |
CA2965377A1 (en) | 2007-03-15 |
CA2621394C (en) | 2018-02-20 |
CA2965377C (en) | 2021-12-14 |
US8993846B2 (en) | 2015-03-31 |
US10752908B2 (en) | 2020-08-25 |
AU2006287650A1 (en) | 2007-03-15 |
US20190211346A1 (en) | 2019-07-11 |
EP3536793A1 (en) | 2019-09-11 |
US20070074314A1 (en) | 2007-03-29 |
ZA200802009B (en) | 2008-12-31 |
JP6046079B2 (en) | 2016-12-14 |
BRPI0615680A2 (en) | 2011-05-24 |
MX2008003190A (en) | 2008-03-18 |
JP6348952B2 (en) | 2018-06-27 |
JP2014193173A (en) | 2014-10-09 |
US20150232865A1 (en) | 2015-08-20 |
JP5889508B2 (en) | 2016-03-22 |
CA2621394A1 (en) | 2007-03-15 |
JP2009506787A (en) | 2009-02-19 |
JP2017074051A (en) | 2017-04-20 |
EP1941046A2 (en) | 2008-07-09 |
JP2016105708A (en) | 2016-06-16 |
WO2007030432A3 (en) | 2007-06-07 |
JP6077631B2 (en) | 2017-02-08 |
WO2007030432A2 (en) | 2007-03-15 |
US10202611B2 (en) | 2019-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210010011A1 (en) | Vectors and methods for improved plant transformation efficiency | |
US10724042B2 (en) | Use of non-Agrobacterium bacterial species for plant transformation | |
JP5329412B2 (en) | Plant transformation without selection | |
US20190376072A1 (en) | Methods and Vectors for Producing Transgenic Plants | |
CN1809639B (en) | DNA constructs and methods to enhance the production of commercially viable transgenic plants | |
AU2013200116A1 (en) | Vectors and methods for improved plant transformation efficiency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |